<< مقالات لاتين >>
<< بر اساس عنوان >>
1
Prognostic factors for survival after isolated limb perfusion for malignant melanoma
2
Prognostic factors for survival after pulmonary resection of metastatic renal cell carcinoma
3
PROGNOSTIC FACTORS FOR SURVIVAL AT 6-MONTH FOLLOW-UP OF HOSPITALIZED PATIENTS WITH DECOMPENSATED CONGESTIVE HEART FAILURE
4
Prognostic factors for survival in pancreatic cancer: a population-based study
5
Prognostic Factors for Survival in Patients with Colorectal Cancer in Iran between 2004-2015: Competing Risks Regression Analysis with Generalized Weibull Model
6
Prognostic factors for survival in previously treated patients with metastatic renal cell carcinoma. Motzer RJ, Bacik J, Schwartz LH, Reuter V, Russo P, Marion S, Mazumdar M, Genitourinary Oncology Service, Division of Solid Tumor Oncology, Department of
7
Prognostic Factors for Survival of Patients with Glioblastoma in the Southern Region of Morocco
8
Prognostic factors for the development of gangrenous cholecystitis
9
Prognostic factors for the survival of patients with esophageal cancer in Northern Iran
10
Prognostic factors for tobacco consumption reduction after relapse
11
Prognostic factors for unstable proximal humeral fractures treated with locking-plate fixation
12
Prognostic factors impacting clinical outcome following Malassezia folliculitis treatment
13
Prognostic factors in acute cardiogenic pulmonary edema
14
Prognostic factors in acute cardiogenic pulmonary edema
15
Prognostic factors in acute myeloid leukaemia
16
Prognostic factors in adenocarcinoma of the cardia
17
Prognostic factors in adult granulosa cell tumor of the ovary
18
Prognostic factors in allogeneic transplantation for patients with high-risk multiple myeloma after reduced intensity conditioning
19
Prognostic factors in birth time: A Survival Analysis
20
Prognostic factors in clinical stage I non–small cell lung cancer
21
Prognostic factors in controlied ovarian hyperstimulation
22
Prognostic Factors in Crescentic Glomerulonephritis A Single-Center Experience
23
Prognostic factors in follicular carcinoma of the thyroid—a multivariate survival analysis
24
Prognostic factors in hanging injuries
25
Prognostic factors in hereditary and sporadic breast cancers: analysis of an Italian series of 602 patients
26
Prognostic factors in intramedullary astrocytomas
27
Prognostic factors in major depression: A long-term follow-up study of 323 patients
28
Prognostic factors in maxillary sinus and nasal cavity carcinoma
29
Prognostic factors in metastatic prostate cancer
30
Prognostic Factors in Multiple Myeloma: National Cancer Institute Experience
31
Prognostic factors in multiple myeloma: selection using Coxʹs proportional hazard model
32
Prognostic factors in neuroendocrine lung tumors: a Spanish multicenter study
33
Prognostic factors in node-negative intrahepatic cholangiocarcinoma with special reference to angiogenesis
34
Prognostic factors in non-small cell lung cancer surgery
35
Prognostic factors in patients continuing in vitro fertilization or intracytoplasmic sperm injection treatment and dropouts
36
Prognostic factors in patients with acute ischemic stroke treated with intravenous tissue plasminogen activator: The first study among Iranian patients
37
Prognostic factors in patients with acute ischemic stroke treated with intravenous tissue plasminogen activator: The first study among Iranian patients
38
PROGNOSTIC FACTORS IN PATIENTS WITH APPENDICULAR MYXOFIBROSARCOMA
39
Prognostic factors in patients with glioblastoma multiforme (clinical research)
40
Prognostic Factors in Patients With Implantable Cardioverter-Defibrillators
41
Prognostic factors in patients with isolated recurrences of breast cancer (stage IV-NED)
42
Prognostic factors in patients with isolated recurrences of breast cancer (stage IV-NED)
43
Prognostic factors in patients with malignant fibrous histiocytoma of the extremities
44
Prognostic factors in patients with surgically resected stages I and II non-small cell lung cancer
45
Prognostic Factors in Resected Satellite–Nodule T4 Non-Small Cell Lung Cancer
46
Prognostic factors in soft tissue leiomyosarcoma of the extremities: a retrospective analysis of 42 cases
47
Prognostic factors in soft tissue sarcomas: a study of 395 patients
48
Prognostic Factors in the Management of Exacerbation of Chronic Obstructive Pulmonary Disease in Kuwait
49
Prognostic factors in the palliation of pancreatic cancer
50
Prognostic Factors in the Relapse of Graves’ Disease Following Treatment with Antithyroid Drugs
51
Prognostic Factors in Thymic Epithelial Tumors Undergoing Complete Resection
52
PROGNOSTIC FACTORS IN TYPHOID ILEAL PERFORATION: A PROSPECTIVE STUDY OF 98 PATIENTS AT SAIDU GROUP OF TEACHING HOSPITALS, SWAT
53
Prognostic factors in metastatic nasopharyngeal carcinoma
54
Prognostic factors of 28 days survival rate in patients with a first acute myocardial
55
Prognostic Factors of Acute Lymphoblastic Leukeamia in Children
56
Prognostic Factors of Anaplastic Thyroid Carcinoma: An Egyptian Single Institution Experience
57
Prognostic factors of Atractylis gummifera L. poisoning, Morocco
58
Prognostic Factors of Concomitant Hyperglycemia and Hypocalcemia in Pediatric Intensive Care Units
59
Prognostic Factors of Depression in Patients With Cancer Undergoing Chemotherapy and Radiotherapy
60
Prognostic factors of extremity soft tissue sarcoma in adults. A single institutional analysis
61
Prognostic factors of first birth interval using the parametric survival models
62
Prognostic Factors of Functional Recovery from Left Hemispheric Stroke
63
Prognostic factors of gastric cancer tumours of less than 2 cm in diameter: rationale for limited surgery
64
prognostic factors of in-hospital mortality in adult patients with aluminum phosphide (alp) poisoning in southern iran (2014-2018)
65
Prognostic Factors of Initial Chest CT Findings for ICU Admission and Mortality in Patients with COVID-19 Pneumonia
66
Prognostic factors of neuroinflammation and oxidative stress in brain injury patients at Cipto Mangunkusumo Hospital Jakarta
67
Prognostic factors of oncologic outcomes after fertility‑preservative management with progestin in early‑stage of endometrial cancer
68
Prognostic Factors of Outcome in Methanol Poisoning; an 8-year Retrospective Cross-sectional Study
69
Prognostic factors of patients with mycosis fungoides
70
Prognostic factors of patients with yolk sac tumors of the ovary
71
Prognostic factors of postoperative intraretinal cystoid spaces after primary pars plana vitrectomy for vitreomacular traction
72
Prognostic Factors of Pregnancy in 500 Cases of Intrauterine Insemination in Babol, Northern Iran
73
Prognostic Factors of Pregnancy in 500 Cases of Intrauterine Insemination in Babol, Northern Iran
74
Prognostic Factors of Radiofrequency Ablation plus Systemic Chemotherapy for Unresectable Colorectal Cancer with Liver Metastasis
75
Prognostic factors of recurrence and neck metastasis in oral carcinomas
76
Prognostic Factors of Renal Dysfunction Induced by Environmental Cadmium Pollution
77
Prognostic Factors of Severe Traumatic Brain Injury Outcome in Children Aged 2-16 Years at A Major Neurosurgical Referral Centre
78
Prognostic Factors of Surgery for Cervical Cord Tumors
79
Prognostic Factors of Survival Rate in Oral Squamous Cell Carcinoma: Clinical, Histologic, Genetic and Molecular Concepts
80
Prognostic factors of thymomas
81
Prognostic factors predicting survival from first recurrence in patients with metastatic breast cancer: analysis of 439 patients
82
Prognostic factors predicting survival from first recurrence in patients with metastatic breast cancer: analysis of 439 patients
83
Prognostic factors predicting survival in the treatment of retroperitoneal sarcoma
84
Prognostic features of multiple myeloma
85
Prognostic histopathological and molecular markers in feline mammary neoplasia
86
Prognostic Impact of Acute Beta-Blocker Therapy on Top of Aspirin and Angiotensin-Converting Enzyme Inhibitor Therapy in Consecutive Patients With ST-Elevation Acute Myocardial Infarction
87
Prognostic Impact of Adjuvant Radiotherapy in Breast Cancer Patients with One to Three Positive Axillary Lymph Nodes
88
Prognostic impact of ambulatory blood pressure control in treated hypertensive patients
89
Prognostic Impact of Angiotensin-Converting Enzyme Inhibitor Therapy in Diastolic Heart Failure
90
Prognostic impact of autonomic information flow in multiple organ dysfunction syndrome patients
91
Prognostic impact of big endothelin-1 plasm concentrations compared with invasive hemodynamic evaluation in severe heart failure
92
Prognostic impact of body weight and abdominal obesity in women and men with cardiovascular disease
93
Prognostic impact of chromosome alterations detected by FISH in Turkish patients with B-cell chronic lymphocytic leukemia
94
Prognostic Impact of Circulating CD28 Negative Suppressor T Cells and Memory B Cells on Treatment Outcomes of Patients with Breast Cancer
95
Prognostic Impact of Cirrhosis in Patients with Intrahepatic Cholangiocarcinoma following Hepatic Resection
96
Prognostic Impact of Cytoreductive Nephrectomy in Patients with Metastatic Renal Cell Carcinoma: Data from a Large Population-Based Database
97
Prognostic impact of definitive local therapy of the primary tumor in men with metastatic prostate cancer at diagnosis: A population-based, propensity score analysis
98
Prognostic impact of Deoxyribonucleic acid (DNA) image analysis cytometry and immunohistochemical expression of Ki67 in surgically resected non-small cell lung cancers
99
Prognostic Impact of Diabetes Mellitus in Patients With Acute Decompensated Heart Failure
100
Prognostic impact of diabetes mellitus in patients with heart failure according to the etiology of left ventricular systolic dysfunction
101
Prognostic impact of DNA content and AUER classification in primary fallopian tube carcinoma
102
Prognostic Impact of Interleukin-10 in Patients with Chronic Lymphocytic Leukemia
103
Prognostic impact of left bundle-branch block in the early stable phase after acute myocardial infarction
104
Prognostic impact of matrix metalloproteinases (MMP-9 and MMP-2) and vascular endothelial growth factor expression in non-small cell lung cancer
105
Prognostic Impact of Monocyte to Lymphocyte Ratio in Clinical Outcome for Patients with Hepatocellular Carcinoma: A Systematic Review and Meta-Analysis
106
Prognostic impact of neuropilin-1 expression in children with B-lineage acute lymphoblastic leukemia: Retraction
107
Prognostic impact of p53 protein overexpression in patients with node-negative lung adenocarcinoma
108
Prognostic impact of peakVO2-changes in stable CHF on chronic beta-blocker treatment
109
Prognostic impact of pre-operative albumin on short-term mortality and complications in patients with hip fracture
110
Prognostic impact of pulmonary arterial hypertension: A population-based analysis
111
Prognostic Impact of Pulmonary Artery Systolic Pressure in Patients Undergoing Transcatheter Aortic Valve Replacement for Aortic Stenosis
112
Prognostic Impact of Q Waves on Presentation and ST Resolution in Patients With ST-Elevation Myocardial Infarction Treated With Primary Percutaneous Coronary Intervention
113
Prognostic impact of renal dysfunction on long-term mortality in patients with preserved, moderately impaired, and severely impaired left ventricular systolic function following myocardial infarction
114
Prognostic impact of right ventricular involvement as assessed by tricuspid annular motion in patients with acute myocardial infarction
115
Prognostic Impact of Staged Versus “One-Time” Multivessel Percutaneous Intervention in Acute Myocardial Infarction: Analysis From the HORIZONS-AMI (Harmonizing Outcomes With Revascularization and Stents in Acute Myocardial Infarction) Trial
116
Prognostic impact of SUMO-specific protease 1 (SENP1) in prostate cancer patients undergoing radical prostatectomy
117
Prognostic impact of SUMO-specific protease 1 (SENP1) in prostate cancer patients undergoing radical prostatectomy
118
Prognostic Impact of Systolic Hypertension on Asymptomatic Patients With Chronic Severe Aortic Regurgitation and Initially Normal Left Ventricular Performance at Rest
119
Prognostic Impact of TEL–AML-1 Fusion Gene on Acute Lymphoblastic Leukemia
120
Prognostic Impact of the Presence and Absence of Angina on Mortality and Cardiovascular Outcomes in Patients With Type 2 Diabetes and Stable Coronary Artery Disease: Results from the BARI 2D (Bypass Angioplasty Revascularization Investigation 2 Diabetes)
121
Prognostic Impact of Thrombolysis in Myocardial Infarction Risk Index on Hospitalization Mortality of Patient with Acute Pulmonary Embolism
122
Prognostic impact of tumor size on pT2 renal cell carcinoma: An international multicenter experience: Klatte T, Patard JJ, Goel RH, Kleid MD, Guille F, Lobel B, Abbou CC, De La Taille A, Tostain J, Cindolo L, Altieri V, Ficarra V, Artibani W, Prayer-Galet
123
Prognostic impact of tumour cell detection in patients with early (T1) and locally advanced breast cancer
124
Prognostic Impact of Types of Atrial Fibrillation in Acute Coronary Syndromes
125
Prognostic impact of workload in patients with congestive heart failure
126
Prognostic Implication and Survival Outcomes of Perioperative Blood Transfusion on Urological Malignancies Undergoing Radical Surgical Intervention
127
Prognostic Implication of Adrenocortical Response during the Course of Critical Illness
128
Prognostic implication of creatine kinase release after elective percutaneous coronary intervention in the pre-IIb/IIIa antagonist era
129
Prognostic implication of early ejection fraction on long-term mortality and quality of life following out-of-hospital cardiac arrest
130
Prognostic Implication of Hyperglycemia in Myocardial Infarction and Primary Angioplasty
131
Prognostic implication of Ki-67 immunostaining in treating subclinical pleural cancer found at thoracotomy in lung cancer patients
132
Prognostic implication of pretreatment plasma/serum concentration of Epstein-Barr virus DNA in nasopharyngeal carcinoma
133
Prognostic implication of redefining indeterminate microvolt T-wave alternans studies as abnormal or normal
134
Prognostic implication of troponin I elevation after percutaneous coronary intervention
135
Prognostic implication of valvular lesion and left ventricular size in asymptomatic patients with chronic organic mitral regurgitation and normal left ventricular performance
136
Prognostic implications derived from ultrasonic tissue characterization with myocardial integrated backscatter in patients with dilated cardiomyopathy
137
Prognostic implications for gastric carcinoma based on loss of heterozygosity genotypes correlation with clinicopathologic variables
138
Prognostic Implications of a Normal Stress Technetium-99m–Tetrofosmin Myocardial Perfusion Study in Patients With a Healed Myocardial Infarct and/or Previous Coronary Revascularization
139
Prognostic implications of ambulatory myocardial ischemia and arrhythmias and relations to ischemia on exercise in chronic stable angina pectoris (the Angina Prognosis Study In Stockholm [APSIS])
140
Prognostic implications of atrial fibrillation in patients undergoing myocardial perfusion single-photon emission computed tomography Original Research Article
141
Prognostic implications of autonomic nervous system analysis in chronic heart failure: Role of heart rate variability and baroreflex sensitivity
142
Prognostic Implications of Baroreflex Sensitivity in Heart Failure Patients in the Beta-Blocking Era
143
Prognostic Implications of Bundle Branch Block in Patients Undergoing Primary Coronary Angioplasty in the Stent Era
144
Prognostic Implications of Coronary Flow Reserve on Left Anterior Descending Coronary Artery in Hypertrophic Cardiomyopathy
145
Prognostic Implications of Creatine Kinase Elevation After Primary Percutaneous Coronary Intervention for Acute Myocardial Infarction Original Research Article
146
Prognostic implications of detection of troponin I in patients with unstable angina pectoris
147
Prognostic Implications of Dipyridamole or Dobutamine Stress Echocardiography for Evaluation of Patients ≥65 Years of Age With Known or Suspected Coronary Heart Disease
148
Prognostic implications of ejection fraction from linear echocardiographic dimensions: the strong heart study
149
Prognostic implications of elevated troponin in patients with suspected acute coronary syndrome but no critical epicardial coronary disease: A TACTICS-TIMI-18 substudy Original Research Article
150
Prognostic implications of elevated whole blood choline levels in acute coronary syndromes
151
Prognostic implications of evaluation of contractile reserve in akinetic and hypokinetic segments during low dose dobutamine echocardiography in patients with acute myocardial infarction
152
Prognostic Implications of Exercise Echocardiography in Women With Known or Suspected Coronary Artery Disease
153
Prognostic implications of fetal echogenic bowel
154
Prognostic implications of hyponatremia in elderly hospitalized patients
155
Prognostic implications of I-123 metaiodobenzylguanidine (MIBG) in patients with idiopathic dilated cardiomyopathy (DCM) and receiving β-blockade treatment
156
Prognostic implications of increased QRS duration in patients with moderate and severe left ventricular systolic dysfunction
157
Prognostic implications of inhalation injury in burn patients in Tokyo
158
Prognostic implications of intraventricular conduction defects in patients undergoing stress echocardiography for suspected coronary artery disease
159
Prognostic Implications of Left Atrial Volume Index in Patients in Sinus Rhythm
160
Prognostic implications of left ventricular hypertrophy
161
Prognostic Implications of Mental Stress-Induced Silent Loft Ventricular Dysfunction in Patients With Stable Angina Pectoris
162
Prognostic implications of microscopic proximal bronchial extension in non-small cell lung cancer
163
Prognostic implications of monosomy 3 in uveal melanoma
164
Prognostic implications of myocardial contractile reserve in patients with coronary artery disease and left ventricular dysfunction
165
Prognostic implications of myocardial necrosis triad markersʹ concentration measured at admission in patients with suspected acute coronary syndrome
166
Prognostic Implications of Nonobstructive Coronary Artery Disease in Patients Undergoing Coronary Computed Tomographic Angiography for Acute Chest Pain
167
Prognostic Implications of Nonobstructive Coronary Plaques in Patients With Non–ST-Segment Elevation Myocardial Infarction: A Multidetector Computed Tomography Study
168
Prognostic Implications of Normal (<0.10 ng/ml) and Borderline (0.10 to 1.49 ng/ml) Troponin Elevation Levels in Critically Ill Patients Without Acute Coronary Syndrome
169
Prognostic Implications of Preoperative Atrial Fibrillation in Patients Undergoing Aortic Valve Replacement: Is There an Argument for Concomitant Arrhythmia Surgery?
170
Prognostic Implications of Prominent R Wave in Electrocardiographic Leads V1 or V2 in Patients With Acute Coronary Syndrome
171
Prognostic Implications of Restrictive Left Ventricular Filling in Acute Myocardial Infarction: Serial Doppler Echocardiographic Study
172
Prognostic implications of restrictive left ventricular filling in reperfused anterior acute myocardial infarction
173
Prognostic Implications of ST-Segment Elevation Resolution in Patients With ST-Segment Elevation Acute Myocardial Infarction Treated With Primary or Facilitated Percutaneous Coronary Intervention
174
Prognostic implications of Tc-99m sestamibi viability imaging and subsequent therapeutic strategy in patients with chronic coronary artery disease and left ventricular dysfunction
175
Prognostic Implications of the Doppler Restrictive Filling Pattern in Hypertrophic Cardiomyopathy
176
Prognostic Implications of the Doppler Restrictive Filling Pattern in Hypertrophic Cardiomyopathy
177
Prognostic Implications of the High-Sensitive C-Reactive Protein in the Catheter Ablation of Atrial Fibrillation
178
Prognostic implications of TIMI flow grade in the infarct related artery compared with continuous 12-lead ST-segment resolution analysis: Reexamining the “gold standard” for myocardial reperfusion assessment
179
Prognostic Importance of Atrial Fibrillation in Implantable Cardioverter-Defibrillator Patients
180
Prognostic importance of complete atrioventricular block complicating acute myocardial infarction
181
Prognostic importance of concomitant heparin with eptifibatide in acute coronary syndromes
182
Prognostic importance of degree of differentiation and cyst rupture in stage I invasive epithelial ovarian carcinoma
183
Prognostic importance of elevated troponin T and creatine kinase after elective angioplasty
184
Prognostic importance of hyponatremia in acute ST-elevation myocardial infarction
185
Prognostic importance of initial response in HIV-1 infected patients starting potent antiretroviral therapy: analysis of prospective studies
186
Prognostic importance of insulin-mediated glucose uptake in aged patients with congestive heart failure secondary to mitral and/or aortic valve disease
187
Prognostic importance of isolated T-wave abnormalities
188
Prognostic importance of lower extremity arterial disease in patients undergoing coronary revascularization in the bypass angioplasty revascularization investigation (BARI)
189
Prognostic importance of lymphopenia in West Nile encephalitis
190
Prognostic importance of marital quality for survival of congestive heart failure
191
Prognostic importance of new small Q waves following Non–ST-Elevation acute coronary syndromes
192
Prognostic importance of presenting symptoms in patients undergoing exercise testing for evaluation of known or suspected coronary disease
193
Prognostic importance of renal function in patients with early heart failure and mild left ventricular dysfunction
194
Prognostic importance of right ventricular infarction in an acute myocardial infarction cohort referred for contemporary percutaneous reperfusion therapy
195
Prognostic Importance of Scintigraphic Left Ventricular Cavity Dilation During Intravenous Dipyridamole Technetium-99m Sestamibi Myocardial Tomographic Imaging in Predicting Coronary Events
196
Prognostic Importance of Secondary Pulmonary Hypertension After Acute Myocardial Infarction
197
Prognostic importance of serial cytokine changes in ascites and pleural effusion in women with severe ovarian hyperstimulation syndrome
198
Prognostic importance of systolic and diastolic function after acute myocardial infarction
199
Prognostic importance of the length of ventricular tachycardia in patients with nonischemic congestive heart failure
200
Prognostic importance of the oxidized product of catecholamines, adrenolutin, in patients with severe heart failure
201
Prognostic importance of the quantification of myocardial viability in revascularized patients with coronary artery disease and moderate-to-severe left ventricular dysfunction
202
Prognostic importance of TLX1 (HOX11) oncogene expression in adults with T-cell acute lymphoblastic leukaemia
203
Prognostic importance of troponin T and creatine kinase after elective angioplasty
204
Prognostic Importance of Wall Motion Abnormalities in Patients With Ischemic Cardiomyopathy and an Implantable Cardioverter-Defibrillator
205
Prognostic importance of weight loss in chronic heart failure and the effect of treatment with angiotensin-converting-enzyme inhibitors: an observational study
206
Prognostic indexes in breast cancer: comparison of the Nottingham and Adelaide indexes
207
Prognostic indicators and burns
208
Prognostic indicators for conventional complete denture therapy: A review of the literature
209
Prognostic indicators for conventional complete denture therapy: A review of the literature
210
Prognostic indicators for long term outcome following radical retropubic prostatectomy for prostate cancer involving the seminal vesicles
211
Prognostic indicators of adverse renal outcome and death in acute kidney injury hospital survivors
212
Prognostic Indicators: Useful for Clinical Care?
213
Prognostic indices and screen-detected cancers: the size factor
214
Prognostic Influence of Diabetes Mellitus on Long-Term Clinical Outcomes and Stent Thrombosis After Drug-Eluting Stent Implantation in Asian Patients
215
Prognostic influence of multiple hepatic metastases from colorectal cancer
216
Prognostic influence of pregnancy before, around, and after diagnosis of breast cancer
217
Prognostic influence of the third Gleason grade in prostatectomy specimens
218
Prognostic information of gastric carcinoma using Goseki system in relation to nuclear organizer region (AgNOR) and proliferating cell nuclear antigen (PCNA) expression
219
Prognostic Information of Glycogen Phosphorylase Isoenzyme BB in Patients With Suspected Acute Coronary Syndrome
220
Prognostic information provided by serial measurements of brain natriuretic peptide in heart failure
221
Prognostic interaction between viability and residual myocardial ischemia by dobutamine stress echocardiography in patients with acute myocardial infarction and mildly impaired left ventricular function
222
Prognostic Interplay of Coronary Artery Calcification and Underlying Vascular Dysfunction in Patients With Suspected Coronary Artery Disease
223
Prognostic markers and new, innovative treatments in renal cell carcinoma
224
Prognostic markers for urothelial cancer: Obstacles and opportunities
225
Prognostic markers in chronic lympocytic leukaemia
226
Prognostic markers in renal cell carcinoma: A focus on the ‘mammalian target of rapamycin’ pathway
227
Prognostic Markers in Thrombolytic Therapy: Looking Beyond Mortality
228
Prognostic Meaning of Coronary Flow Reserve in Type 2 Diabetes Mellitus: A Transoesophageal Doppler Echo cardiographic Study
229
Prognostic methods in medicine
230
PROGNOSTIC MODELLING OF CRACK GROWTH IN A TENSIONED STEEL BAND
231
Prognostic models in chronic liver disease: validity, usefulness and future role
232
Prognostic models including the Child–Pugh, MELD and Mayo risk scores—where are we and where should we go?
233
Prognostic normative reasoning
234
Prognostic normative reasoning
235
Prognostic patch testing: The other kind of patch test
236
Prognostic patch testing: The other kind of patch test
237
Prognostic performance of ECG abnormalities compared to vital signs in acutely ill patients in a resource-poor hospital in Uganda
238
Prognostic Performance of High Expression of KIF23 and Loss of c-CBL in Gastric Cancer Patients: An Immunohistochemical Study
239
Prognostic Performance of Multiple Biomarkers in Patients With Non–ST-Segment Elevation Acute Coronary Syndrome: Analysis From the MERLIN–TIMI 36 Trial (Metabolic Efficiency With Ranolazine for Less Ischemia in Non−ST-Elevation Acute Coronary Syndromes–Th
240
Prognostic personal credit risk model considering censored information
241
Prognostic potential of glutathione S-transferase M1 and T1 null genotypes for gastric cancer progression
242
Prognostic prediction in patients with metastatic renal cell carcinoma treated with sorafenib based on expression levels of potential molecular markers in radical nephrectomy specimens
243
Prognostic Prediction Value of qSOFA, SOFA, and Admission Lactate in Septic Patients with Community-Acquired Pneumonia in Emergency Department
244
Prognostic predictors of gastrointestinal stromal tumors: a multi-institutional analysis of 102 patients with definition of a prognostic index
245
Prognostic relevance of AgNORs in tumor pathology
246
Prognostic relevance of cyclooxygenase-2 (COX-2) expression in Chinese patients with prostate cancer
247
Prognostic relevance of Masaoka and Müller-Hermelink classification in patients with thymic tumors
248
Prognostic Relevance of Metabolic Syndrome in Hypertensive Patients at Low-to-Medium Risk
249
Prognostic relevance of mitotic activity in patients with node negative breast cancer
250
Prognostic Relevance of Monosomy at the 13q14 Locus Detected by Fluorescence In Situ Hybridization in B-Cell Chronic Lymphocytic Leukemia
251
Prognostic relevance of occult tumour cells in lymph nodes in colorectal cancer
252
Prognostic relevance of preoperative circulating CD8-positive lymphocytes in the urinary bladder recurrence of urothelial carcinoma
253
Prognostic relevance of receptor tyrosine kinase expression in breast cancer: A meta-analysis
254
Prognostic relevance of ultra-early doppler sonography in acute ischaemic stroke: a prospective multicentre study
255
Prognostic risk stratification derived from individual patient level data for men with advanced penile squamous cell carcinoma receiving first-line systemic therapy
256
Prognostic Role of Body Mass Index After Acute Myocardial Infarction
257
Prognostic role of B-type natriuretic peptide levels in patients with type 2 diabetes mellitus Original Research Article
258
Prognostic role of cardiovascular risk factors for men with cardiomegaly (the Reykjavik study)
259
Prognostic Role of CD44, Smoothelin and MUC1 in Urinary Bladder Carcinoma
260
Prognostic Role of CMR Imaging After Myocardial Infarction
261
Prognostic role of C-reactive protein in acute stroke
262
Prognostic role of cyclooxygenase-2 expression in esophageal carcinoma
263
Prognostic Role of Epithelial Mesenchymal Transition Transcription Factors in Carcinoma- A Systematic Review and Meta-Analysis
264
Prognostic role of fish detected her-2/neu amplification in early onset breast cancer
265
Prognostic Role of Flow-Mediated Dilation and Cardiac Risk Factors in Post-Menopausal Women Original Research Article
266
Prognostic Role of Gestational Age and Birth Weight in Nephrotic Syndrome: A Retrospective Cross-Sectional Study
267
Prognostic role of heart rate variability in patients with a recent acute myocardial infarction
268
Prognostic Role of Human Epidermal Growth Factor Receptor in Gastric Cancer: A Systematic Review and Meta-analysis
269
Prognostic role of immunosuppressive acidic protein in advanced ovarian cancer, , ,
270
Prognostic role of lymph-node level involvement in patients undergoing axillary dissection for breast cancer
271
Prognostic Role of Matrix Metalloproteinase-9 (MMP-9) in Patients with Osteosarcoma
272
Prognostic Role of Neutrophil to Lymphocyte Ratio and Platelet to Lymphocyte Ratio in the Survival of Patients with Esophageal Cancer
273
Prognostic role of oestrogen, progesterone and androgen receptor in relation to patient age in patients with breast cancer
274
Prognostic role of reversible endothelial dysfunction in hypertensive postmenopausal women
275
Prognostic role of simplified Pulmonary Embolism Severity Index and the European Society of Cardiology Prognostic Model in short- and long-term risk stratification in pulmonary embolism
276
Prognostic role of soluble suppression of tumorigenicity-2 on cardiovascular mortality in outpatients with heart failure
277
Prognostic Role of Spiritual Intelligence Components in Pregnant Women’s Depression, Anxiety, and Stress
278
Prognostic role of subclinical left ventricular abnormalities and impact of transplantation in chronic kidney disease
279
Prognostic role of Tc-99m pertechnetate thyroid scintigraphy prior to fixed-dose radioiodine therapy of toxic multinodular goiters
280
Prognostic role of transesophageal echocardiography in acute type A aortic dissection
281
Prognostic Role of Troponin T Versus Troponin I in Unstable Angina Pectoris for Cardiac Events With Meta-Analysis Comparing Published Studies
282
Prognostic Serum Factors in Traumatic Brian Injury: A Systematic Review
283
Prognostic Significance and Determinants of Myocardial Salvage Assessed by Cardiovascular Magnetic Resonance in Acute Reperfused Myocardial Infarction
284
Prognostic significance and different properties of survivin splicing variants in gastric cancer
285
Prognostic Significance of a Clearly Audible Fourth Heart Sound Detected a Month After an Acute Myocardial Infarction
286
Prognostic Significance of a Histologic Subtype in Small Adenocarcinoma of the Lung: The Impact of Nonbronchioloalveolar Carcinoma Components
287
Prognostic Significance of Admission Heart Failure in Patients With Non–ST-Elevation Acute Coronary Syndromes (from the Canadian Acute Coronary Syndrome Registries)
288
Prognostic significance of an elevated creatine kinase in the absence of an elevated troponin I during an acute coronary syndrome
289
Prognostic significance of anemia in patients with chronic systolic heart failure secondary to Chagas’ cardiomyopathy
290
Prognostic Significance of Angina Pectoris ≥30 Days Before Acute Myocardial Infarction in Patients ≥75 Years of Age
291
Prognostic significance of apoptosis in laryngeal cancer. A quantitative immunomorphological study
292
Prognostic Significance of Atrial Fibrillation and Severity of Symptoms of Heart Failure in Patients With Low Gradient Aortic Stenosis and Preserved Left Ventricular Ejection Fraction
293
Prognostic significance of atrial fibrillation in patients at a tertiary medical center referred for heart transplantation because of severe heart failure
294
Prognostic significance of atrial fibrillation/atrial flutter in patients with acute myocardial infarction treated with percutaneous coronary intervention
295
Prognostic significance of Aurora-A expression in human bladder cancer
296
Prognostic significance of axillary node and infraclavicular lymph node status after mastectomy
297
Prognostic significance of B7-H3 expression in patients with colorectal cancer: A meta-analysis
298
Prognostic significance of bcl-2 expression in resected pN2 non-small cell lung cancer
299
PROGNOSTIC SIGNIFICANCE OF BCL-2, BAX AND P53 EXPRESSION IN BREAST CANCER
300
Prognostic significance of Bcl-2, p53 overexpression, and lymph node metastasis in surgically staged endometrial carcinoma
301
Prognostic significance of Bcl-xL gene expression in human colorectal cancer
302
Prognostic significance of blood pressure variability in essential hypertension.
303
Prognostic Significance of Body Mass Index and Other Tumor and Patient Characteristics in Non- Metastatic Renal Cell Carcinoma
304
Prognostic Significance of Bone-marrow Pattern and Immunophenotypic Score in B-chronic Lymphocytic Leukemia at Diagnosis
305
Prognostic significance of brain-derived neurotrophic factor levels in patients with heart failure and reduced left ventricular ejection fraction
306
Prognostic Significance of Carcinoembryonic Antigen Level in Pleural Lavage Fluid for Patients With Lung Adenocarcinoma
307
Prognostic Significance of Carcinoembryonic Antigen Level in Pleural Lavage Fluid for Patients With Lung Adenocarcinoma
308
Prognostic significance of carcinoembryonic antigen levels in peritoneal washes in patients with gastric cancer
309
Prognostic significance of caspase-3 expression in primary resected esophageal squamous cell carcinoma
310
Prognostic significance of CD44v5 expression in human thymic epithelial neoplasms
311
Prognostic significance of cerebrovascular and peripheral arterial disease in patients having percutaneous coronary interventions
312
Prognostic significance of cerebrovascular disease in 11,526 chronic coronary artery disease patients
313
Prognostic significance of CHADS2 and CHA2DS2-VASc scores to predict unfavorable outcomes in hospitalized patients with COVID-19
314
Prognostic significance of changes in the compliance of the pulmonary venous system after isosorbiddinitrate in patients with mitral stenosis
315
Prognostic significance of chronotropic response to dobutamine stress echocardiography in patients with peripheral arterial disease
316
Prognostic Significance of Circulating and Disseminated Tumor Cells in Breast Cancer Patients before and after Adjuvant Chemotherapy
317
Prognostic Significance of Circulating IL-10 and IL-6 Serum Levels in Colon Cancer Patients Undergoing Surgery
318
Prognostic significance of circulating levels of angiogenic cytokines in patients with congestive heart failure
319
Prognostic significance of circulating P53 antibodies in patients undergoing surgery for locoregional breast cancer
320
Prognostic significance of clinically silent coronary artery fistulas
321
Prognostic significance of clinicopathologic and deoxyribonucleic acid flow cytometric variables in non-metastatic renal cell carcinoma in the modern era
322
Prognostic significance of CLLU1 expression in B-cell chronic lymphocytic leukemia
323
Prognostic significance of coronary artery calcium in asymptomatic subjects with usual cardiovascular risk
324
Prognostic significance of coronary blood flow velocity patterns in patients with reperfused acute myocardial infarction and TIMI-2 flow
325
Prognostic significance of coronary blood flow velocity patterns in patients with reperfused acute myocardial infarction and TIMI-2 flow: Reply
326
Prognostic Significance of Coronary Calcific Deposits in Asymptomatic High-Risk Subjects
327
Prognostic Significance of Coronary Collaterals in Patients With Coronary Heart Disease Having Percutaneous Transluminal Coronary Angioplasty
328
Prognostic significance of COX-2 and β-catenin in colorectal carcinoma
329
Prognostic significance of creatine kinase-MB elevation after percutaneous coronary intervention in patients with chronic renal dysfunction
330
Prognostic significance of cytochrome C release and tissue lactate dehydrogenase in patients with breast cancer
331
Prognostic significance of cytogenetically detected chromosome 21 anomalies in childhood acute lymphoblastic leukemia: a Pediatric Oncology Group study
332
Prognostic Significance of Cytokeratin Markers in Breast Cancer –a Meta Analysis
333
Prognostic significance of del 17p,ZAP-70 and CD38 as independent indicators for B-CLL: Correlation to response to treatment and disease outcome
334
Prognostic significance of del(20q) in patients with hematological malignancies
335
Prognostic significance of diabetes as a predictor of survival after cardiac catheterization
336
Prognostic significance of diabetes in acute myocardial infarction. Are the differences linked to female gender?
337
Prognostic significance of diabetes in acute myocardial infarction. Are the differences linked to female gender?
338
Prognostic significance of difficulties in mobility in a five-year follow-up study of four birth cohorts
339
Prognostic significance of DNA ploidy in squamous cell lung carcinoma: is it really worth it?
340
Prognostic significance of DNA ploidy in Ta/Tl bladder cancer: A southwest oncology group study
341
Prognostic significance of DNA ploidy pattern in osteosarcomas in association with chemotherapy
342
Prognostic significance of double product and inadequate double product response to maximal symptom-limited exercise stress testing after myocardial infarction in 6296 patients treated with thrombolytic agents
343
Prognostic significance of early short-term measurements of heart rate variability following acute myocardial infarction
344
Prognostic significance of echocardiographically defined mitral regurgitation early after acute myocardial infarction
345
Prognostic significance of echocardiographically estimated right ventricular shortening in advanced heart failure
346
Prognostic significance of EGF receptor expression in early glottic cancer
347
Prognostic Significance of Elevated Cardiac Troponin I After Heart Surgery
348
Prognostic significance of elevated hemostatic markers in patients with acute myocardial infarction
349
Prognostic significance of elevated troponin i after percutaneous coronary intervention
350
Prognostic Significance of Epicardial Blood Flow Before and After Percutaneous Coronary Intervention in Patients With Acute Coronary Syndromes Original Research Article
351
Prognostic significance of ERRB3 overexpression in oral squamous cell carcinoma
352
Prognostic significance of erythropoietin expression in human renal cell carcinoma: Michael A, Politi E, Havranek E, Corbishley C, Karapanagiotou L, Anderson C, Relph K, Syrigos KN, Pandha H, Department of Oncology, St. George’s Hospital Medical School, L
353
Prognostic Significance of Exercise Induced Arrhythmias and Echocardiographic Variables in Hypertrophic Cardiomyopathy
354
Prognostic significance of exercise stress echocardiography in 3329 outpatients (5-year longitudinal study)
355
Prognostic significance of exercise-induced systemic hypertension in healthy subjects
356
Prognostic significance of fixed perfusion abnormalities on stress technetium-99m sestamibi single-photon emission computed tomography in patients without known coronary artery disease
357
Prognostic significance of flow cytometric quantification of circulating endothelial cells in chronic lymphocytic leukemia
358
Prognostic Significance of Fluorine-18 Fluorodeoxyglucose Positron Emission Tomography in Anal Squamous Cell Carcinoma: A Systematic Review and a Meta-Analysis
359
Prognostic Significance of Fragmented QRS Complex for Predicting the Risk of Recurrent Cardiac Events in Patients With Q-Wave Myocardial Infarction
360
Prognostic significance of glutamine synthetase expression in unifocal advanced hepatocellular carcinoma
361
PROGNOSTIC SIGNIFICANCE OF GLUTATHIONE S-TRANSFERASE µ3 mRNA EXPRESSION IN ACUTE LYMPHOBLASTIC LEUKEMIA
362
Prognostic significance of heart rate turbulence in patients undergoing coronary artery bypass grafting
363
Prognostic significance of heart rate variability in dilated cardiomyopathy
364
Prognostic significance of hepatic encephalopathy in patients with cirrhosis
365
Prognostic significance of HER2, p53, Ki67, MVD-CD34, Cox2, MMP7, and vimentin in gastric cancer
366
Prognostic significance of HER-2/neu overexpression in stage I adenocarcinoma of lung
367
Prognostic Significance of High Sensitivity C-Reactive Protein before and after Percutaneous Coronary Intervention in Patients with Angina Pectoris
368
Prognostic significance of history of stroke among 11507 patients with coronary artery disease
369
Prognostic significance of HOXD4 protein expression in human ovarian cancers
370
Prognostic Significance of Hyponatremia Among Ambulatory Patients With Heart Failure and Preserved and Reduced Ejection Fractions
371
Prognostic significance of immune activation after acute coronary syndromes
372
Prognostic Significance of Impaired Baroreflex Sensitivity Assessed from Phase IV of the Valsalva Maneuver in a Population-Based Sample of Middle-Aged Subjects
373
Prognostic significance of impairment of heart rate response to exercise: Impact of left ventricular function and myocardial ischemia
374
Prognostic Significance of Incident Complete Left Bundle Branch Block Observed Over a 40-Year Period
375
Prognostic Significance of Increased Left Ventricular Mass Index to Mortality and Sudden Death in Patients With Stable Coronary Heart Disease (from the Heart and Soul Study)
376
Prognostic significance of indeterminate lung nodules in renal cell carcinoma
377
Prognostic significance of intracellular survivin in myeloid blast cells as an inhibitor of apoptosis in Egyptian adult acute myeloid leukemia patients
378
Prognostic significance of intra-tumoral estradiol level in breast cancer patients
379
Prognostic significance of intratumoural microvessel density (IMD) in resected pancreatic and ampullary cancers to standard histopathological variables and survival
380
Prognostic significance of Ki-67 and topoisomerase II alpha expression in infiltrating ductal carcinoma of the breast
381
Prognostic significance of Ki-67 and topoisomerase II alpha expression in infiltrating ductal carcinoma of the breast
382
Prognostic significance of late-peaking left ventricular velocity contour in patients with aortic stenosis undergoing valve replacement, ,
383
Prognostic Significance of Left Anterior Hemiblock in Patients With Suspected Coronary Artery Disease Original Research Article
384
Prognostic Significance of Left Atrial Size in Patients With Hypertrophic Cardiomyopathy (from the Italian Registry for Hypertrophic Cardiomyopathy)
385
Prognostic significance of left ventricular diastolic dysfunction in essential hypertension
386
Prognostic Significance of Left Ventricular Diastolic Dysfunction in Patients With Left Ventricular Hypertrophy and Systemic Hypertension (the LIFE Study)
387
Prognostic Significance of LGE by CMR in Aortic Stenosis Patients Undergoing Valve Replacement
388
Prognostic significance of low HDL-C and high triglycerides among diabetic coronary patients
389
Prognostic significance of lymph node metastasis found during pulmonary metastasectomy for extrapulmonary carcinoma
390
Prognostic significance of lymph node reactivity in the control of pathologic negative node squamous cell carcinomas of the oral cavity
391
Prognostic significance of lymphovascular invasion in surgically cured rectal carcinoma
392
Prognostic significance of major histocompatibility complex class II antigens (HLA-DR) in normal colonic mucosa, tubulovillous adenoma, and invasive colonic carcinoma
393
Prognostic Significance of Mammary Tumor Suppressor Gene MASPIN in Breast Cance
394
Prognostic significance of maximal exercise testing after myocardial infarction treated with thrombolytic agents: the GISSI-2 data-base
395
Prognostic Significance of Metastasis to the Highest Mediastinal Lymph Node in Nonsmall Cell Lung Cancer
396
Prognostic Significance of Metastatic Lymph Node Ratio in Patients with Gastric Cancer: an Evaluation in North-East of Iran
397
Prognostic Significance of MGMT Promoter Methylation in Egyptian GBM Patients: A Single-institution Experience
398
Prognostic Significance of MGMT Promoter Methylation in Patients with Glioblastoma Undergoing Surgical Intervention: A Retrospective Study in Northeastern Iran
399
Prognostic significance of microalbuminuria in non-diabetic patients with acute myocardial infarction
400
Prognostic significance of microsatellite instability in curatively resected adenocarcinoma of the small intestine
401
Prognostic Significance of Microvessel Density in Invasive Ductal Carcinoma of Breast
402
Prognostic significance of microvessel density, vascular cuffing and vascular endothelial growth factor expression in ovarian carcinoma: a special review for clear cell adenocarcinoma
403
Prognostic significance of mild mitral regurgitation by color Doppler echocardiography in acute myocardial infarction
404
Prognostic significance of mitral regurgitation and tricuspid regurgitation in patients with left ventricular systolic dysfunction
405
Prognostic Significance of MMP2 and MMP9 Functional Promoter Single Nucleotide Polymorphisms in Head and Neck Squamous Cell Carcinoma
406
Prognostic significance of morphological subtypes in canine malignant lymphomas during chemotherapy
407
Prognostic significance of morphometric endomyocardial biopsy analysis in patients with idiopathic dilated cardiomyopathy
408
Prognostic Significance of Myocardial Fibrosis in Hypertrophic Cardiomyopathy
409
Prognostic Significance of Myocardial Fibrosis Quantification by Histopathology and Magnetic Resonance Imaging in Patients With Severe Aortic Valve Disease
410
Prognostic Significance of Myocardial Ischemia by Dobutamine Stress Echocardiography in Patients Without Angina Pectoris After Coronary Revascularization
411
Prognostic Significance of Myocardial Ischemia Detected by Ambulatory Electrocardiography, Exercise Treadmill Testing, and Electrocardiogram at Rest to Predict Cardiac Events by One Year (The Asymptomatic Cardiac Ischemia Pilot [ACIP] Study)
412
Prognostic Significance of Myocardial Ischemia During Dobutamine Stress Echocardiography in Asymptomatic Patients With Diabetes Mellitus and No Prior History of Coronary Events
413
Prognostic significance of neuroendocrine differentiation in adenocarcinoma of the lung
414
Prognostic significance of newly acquired bundle branch block after aortic valve replacement
415
Prognostic significance of nocturnal BP for developing microalbuminuria in IDDM
416
Prognostic significance of nonfatal reinfarction during 3-year follow-up: Results of the thrombolysis in myocardial infarction (TIMI) phase II clinical trial
417
Prognostic significance of non-muscle-invasive bladder tumor history in patients with upper urinary tract urothelial carcinoma
418
Prognostic significance of non-muscle-invasive bladder tumor history in patients with upper urinary tract urothelial carcinoma
419
Prognostic Significance of Nonsustained Ventricular Tachycardia During Dobutamine Stress Echocardiography
420
Prognostic significance of normal dobutamine-atropine stress sestamibi scintigraphy in women with chest pain
421
Prognostic Significance of Notch-4, SATB-2, and Glutaminase-1 in Colorectal Adenocarcinoma
422
Prognostic significance of N-Terminal Pro-BNP in patients with COVID-19 pneumonia without previous history of heart failure
423
Prognostic Significance of Nuclear βCatenin Expression in Patients with Colorectal Cancer from Iran
424
Prognostic Significance of Nuclear β-Catenin Expression in Patients with Colorectal Cancer from Iran
425
Prognostic Significance of Oxidative Stress Markers in Colitis Associated with Phenylbutazone Administration in Draft Horses
426
Prognostic significance of oxygen uptake kinetics during low level exercise in patients with heart failure
427
Prognostic significance of p16INK4a/p53 in Tunisian patients with breast carcinoma
428
Prognostic significance of p53 and p63 immunolocalisation in primary and matched lymph node metastasis in oral squamous cell carcinoma
429
Prognostic significance of p53 mutation in suboptimally resected advanced ovarian carcinoma treated with the combination chemotherapy of paclitaxel and carboplatin
430
Prognostic significance of p53 mutations in non-small cell lung cancer: a meta-analysis of 829 cases from eight published studies
431
Prognostic significance of p53, bax and bcl-2 gene expression in patients with laryngeal carcinoma
432
Prognostic significance of P53,Bcl-2,and fas expression in patients with primary gastrointestinal diffuse large B-cell lymphoma
433
Prognostic Significance of PD-L1 and PTEN Expression in Prostatic Cancer
434
Prognostic significance of peri-operative blood transfusion following radical resection for oesophageal carcinoma,
435
Prognostic significance of perioperative serum carcinoembryonic antigen in non-small cell lung cancer: analysis of 1,000 consecutive resections for clinical stage I disease
436
Prognostic significance of peripheral monocytosis after reperfused acute myocardial infarction:a possible role for left ventricular remodeling
437
Prognostic Significance of Periprocedural Versus Spontaneously Occurring Myocardial Infarction After Percutaneous Coronary Intervention in Patients With Acute Coronary Syndromes: An Analysis From the ACUITY (Acute Catheterization and Urgent Intervention T
438
Prognostic significance of persistent right ventricular dysfunction as assessed by radionuclide angiocardiography in patients with inferior wall acute myocardial infarction
439
Prognostic significance of positive surgical margins after radical prostatectomy among pT2 and pT3a prostate cancer
440
Prognostic significance of positive surgical margins after radical prostatectomy among pT2 and pT3a prostate cancer
441
Prognostic Significance of Postprocedural Sustained Ventricular Tachycardia or Fibrillation in Patients Undergoing Primary Percutaneous Coronary Intervention (from the HORIZONS-AMI Trial)
442
Prognostic significance of precordial ST segment depression during inferior myocardial infarction in the thrombolytic era: Results in 16,521 patients
443
Prognostic significance of precordial ST segment depression on admission electrocardiogram in patients with inferior wall myocardial infarction
444
Prognostic Significance of Preoperative CA72-4 in Patients with Esophageal Squamous Cell Carcinoma
445
Prognostic significance of primary Gleason pattern in Japanese men with Gleason score 7 prostate cancer treated with radical prostatectomy
446
Prognostic significance of primary Gleason pattern in Japanese men with Gleason score 7 prostate cancer treated with radical prostatectomy
447
Prognostic significance of prior preterm twin delivery on subsequent singleton pregnancy
448
Prognostic significance of prostate cancer originating from the transition zone
449
Prognostic Significance of QRS Duration in Patients With Suspected Coronary Artery Disease Referred for Noninvasive Evaluation of Myocardial Ischemia
450
Prognostic Significance of Quantitative QRS Duration
451
Prognostic significance of raised plasma levels of interleukin-6 and C-reactive protein in atrial fibrillation
452
Prognostic significance of reactivation of telomerase in breast core biopsy specimens
453
Prognostic Significance of Reduction in Ki67 Index After Neoadjuvant Chemotherapy in Patients With Breast Cancer in Kerman Between 2009 an‎d 2014
454
Prognostic significance of renal insufficiency in patients presenting with acute coronary syndrome (the Prospective Multicenter SYCOMORE study)
455
Prognostic significance of residual cumulative ST-segment deviation after mechanical reperfusion in patients with ST-segment elevation myocardial infarction
456
Prognostic significance of retrieved lymph nodes per specimenin resected rectal adenocarcinoma after preoperative chemoradiation therapy
457
Prognostic significance of RIN1 gene expression in human non-small cell lung cancer
458
Prognostic significance of selected immunological and biochemical parameters in the cerebrospinal fluid of Ossimi sheep with encephalitic listeriosis
459
Prognostic significance of serum anti-p53 antibody in patients with hepatocellular carcinoma
460
Prognostic significance of serum creatinine concentration for in-hospital mortality in patients with acute myocardial infarction who underwent successful primary percutaneous coronary intervention (from the Heart Institute of Japan Acute Myocardial Infarc
461
Prognostic significance of serum monoclonal immunoglobulin in B-chronic lymphocytic leukemia
462
Prognostic Significance of Serum Total Cholesterol and Triglyceride Levels in Patients Hospitalized for Heart Failure With Reduced Ejection Fraction (from the EVEREST Trial)
463
Prognostic significance of sICAM-1 and sVCAM-1 molecules for cardiac surgery in pediatric patients with pulmonary hypertension
464
Prognostic significance of simvastatin therapy in patients with ischemic heart failure who underwent percutaneous coronary intervention for acute myocardial infarction
465
Prognostic significance of six-minute walk test in non-group 1 pulmonary hypertension
466
Prognostic Significance of Small Troponin I Rise After a Successful Elective Percutaneous Coronary Intervention of a Native Artery
467
Prognostic Significance of Small Troponin I Rise After a Successful Elective Percutaneous Coronary Intervention of a Native Artery
468
Prognostic significance of soluble interleukin-2 receptor-α in adenocarcinoma of the pancreas
469
Prognostic significance of spectral turbulence analysis of the signal-averaged electrocardiogram in patients with idiopathic dilated cardiomyopathy
470
Prognostic Significance of Spontaneous Echo Contrast in the Thoracic Aorta: Relation With Accelerated Clinical Progression of Coronary Artery Disease
471
Prognostic significance of ST segment depression in lateral leads I, aVL, V5 and V6 on the admission electrocardiogram in patients with a first acute myocardial infarction without ST segment elevation
472
Prognostic significance of ST segment monitoring early after myocardial infarction: GUSTO ECG substudy
473
Prognostic Significance of ST Segment Shift Early After Resolution of ST Elevation in Patients With Myocardial Infarction Treated With Thrombolytic Therapy: The GUSTO-I ST Segment Monitoring Substudy
474
Prognostic significance of STAT3 expression and its correlation with chemoresistance of non-small cell lung cancer cells
475
Prognostic significance of stathmin expression in correlation with metastasis and clinicopathological characteristics in human ovarian carcinoma
476
Prognostic significance of ST-segment depression during adenosine perfusion imaging
477
Prognostic significance of ST-segment elevation during dobutamine stress echocardiography
478
Prognostic Significance of Substance P and Neurokinin-1 Receptor in Bladder Cancer
479
Prognostic significance of surgical-pathologic N1 disease in non-small cell carcinoma of the lung
480
Prognostic Significance of Survivin and Nuclear Morphometry in Nasopharyngeal Carcinoma
481
Prognostic Significance of Systolic Blood Pressure Changes During Dobutamine-Atropine Stress Technetium-99m Sestamibi Perfusion Scintigraphy in Patients With Chest Pain and Known or Suspected Coronary Artery Disease
482
Prognostic Significance of Systolic Blood Pressure During Exercise Stress Testing
483
Prognostic Significance of Systolic Blood Pressure Increases in Men During Exercise Stress Testing
484
Prognostic significance of the admission electrocardiogram in acute myocardial infarction
485
Prognostic significance of the coexpression of p53 protein and c-erbB2 in breast cancer
486
Prognostic significance of the dobutamine echocardiography test in idiopathic dilated cardiomyopathy
487
Prognostic significance of the expression levels of the p16, p15, and p14 genes in dogs with high-grade lymphoma
488
Prognostic significance of the location of wall motion abnormalities during exercise echocardiography
489
Prognostic Significance of the Neutrophil-to-Lymphocyte Ratio in Patients with Non-Muscle Invasive Bladder Cancer treated with Intravesical Bacillus Calmette–Guérin and the Relationship with the CUETO Scoring Model
490
Prognostic Significance of the Oxygen Uptake Efficiency Slope: Percent-Predicted Versus Actual Value
491
Prognostic significance of the pouch sign in fetuses with prenatally diagnosed esophageal atresia,
492
Prognostic significance of the size of central fibrosis in peripheral adenocarcinoma of the lung
493
Prognostic Significance of the Tumor Suppressor Gene Maspin in Non–Small Cell Lung Cancer
494
Prognostic Significance of Thrombocytosis in Patients with Locally Advanced Cervical Carcinoma Treated with Chemoradiotherapy
495
Prognostic significance of thymomas in patients with myasthenia gravis
496
Prognostic significance of total number of nodes removed, negative nodes removed, and ratio of positive nodes to removed nodes in node positive breast carcinoma
497
Prognostic significance of TP53 expression for patients with hepatocellular carcinoma: a meta-analysis
498
Prognostic significance of TPA versus SCC-Ag, CEA and neopterin in carcinoma of the uterine cervix
499
Prognostic significance of transient complete atrioventricular block during radiofrequency ablation of atrioventricular node reentrant tachycardia
500
Prognostic significance of transient ischemic episodes: Response to treatment shows improved prognosis Results of the total ischemic burden bisoprolol study (TIBBS) follow-up
501
Prognostic significance of transient no-reflow during primary percutaneous coronary intervention for ST-elevation acute myocardial infarction
502
Prognostic significance of trisomy 6 in an adult acute myeloid leukemia with t(8;21)
503
Prognostic Significance of Troponin Elevation and Right Ventricular Enlargement in Acute Pulmonary Embolism
504
Prognostic Significance of Troponin T Elevation in Patients Without Chest Pain
505
Prognostic significance of troponin T following elective percutaneous coronary intervention: The role of baseline troponin levels
506
Prognostic Significance of TRPS1, GATA3, and CYP4Z1 Expression in Triple-Negative Breast Cancer Patients: An Immunohistochemical Study
507
Prognostic significance of tumor angiogenesis in epithelial ovarian cancer
508
Prognostic significance of tumor angiogenesis in primary fallopian tube cancer
509
Prognostic Significance of Tumor Location in Oncologic Outcome of Colon Cancer
510
Prognostic significance of tumor oxygenation in humans
511
Prognostic significance of two sub-categorization methods for the treatment of binge eating disorder: Negative affect and overvaluation predict, but do not moderate, specific outcomes
512
Prognostic Significance of Valvuloarterial Impedance and Left Ventricular Longitudinal Function in Asymptomatic Severe Aortic Stenosis Involving Three-Cuspid Valves
513
Prognostic significance of vascular endothelial growth factor expression in hepatocellular carcinoma tissue: a meta-analysis
514
Prognostic Significance of VEGF-C Expression in Patients with Breast Cancer: A Meta-Analysis
515
Prognostic stratification of diabetic patients by exercise echocardiography
516
Prognostic Stratification of Patients with Left-Sided Endocarditis Determined at Admission
517
Prognostic stratification of patients with right bundle branch block using dobutamine stress echocardiography
518
Prognostic Stratification of Patients With Vasospastic Angina
519
Prognostic Stratification of Patients With Vasospastic Angina: A Comprehensive Clinical Risk Score Developed by the Japanese Coronary Spasm Association
520
Prognostic studies of canine and feline mammary tumours: The need for standardized procedures
521
Prognostic studies of mammary and other neoplasia in veterinary medicine: A new paradigm
522
Prognostic use of circulating plasma nucleic acid concentrations in patients with acute stroke
523
Prognostic use of echocardiography 1 year after a myocardial infarction
524
Prognostic usefulness of an increase of N-terminal proatrial natriuretic peptide during exercise in patients with chronic heart failure
525
Prognostic Usefulness of Anemia and N-Terminal Pro-Brain Natriuretic Peptide in Outpatients With Systolic Heart Failure
526
Prognostic Usefulness of Circulating High-Sensitivity Troponin T in Aortic Stenosis and Relation to Echocardiographic Indexes of Cardiac Function and Anatomy
527
Prognostic Usefulness of Clinical and Subclinical Peripheral Arterial Disease in Men With Stable Coronary Heart Disease
528
Prognostic Usefulness of C-Reactive Protein: Importance of the Diurnal Variation
529
Prognostic usefulness of dobutamine-induced ST-segment elevation and T-wave normalization after uncomplicated acute myocardial infarction
530
Prognostic Usefulness of Dyspnea Versus Fatigue as Reason for Exercise Test Termination in Patients With Heart Failure
531
Prognostic usefulness of echocardiographic dobutamine in younger (14 to 25 years) and older (40 to 55 years) patients with idiopathic dilated cardiomyopathy
532
Prognostic Usefulness of Free Fatty Acids in Patients With Stable Coronary Heart Disease
533
Prognostic Usefulness of Insulin-Like Growth Factor-Binding Protein 7 in Heart Failure With Reduced Ejection Fraction: A Novel Biomarker of Myocardial Diastolic Function?
534
Prognostic Usefulness of Left Ventricular Hypertrophy by Electrocardiography in Patients With Atrial Fibrillation (from the Randomized Evaluation of Long-Term Anticoagulant Therapy Study)
535
Prognostic usefulness of left ventricular thrombus by echocardiography in dilated cardiomyopathy in predicting stroke, transient ischemic attack, and death
536
Prognostic usefulness of marginal troponin T elevation
537
Prognostic usefulness of plasma monocyte/macrophage and T-lymphocyte activation markers in patients with acute coronary syndromes
538
Prognostic usefulness of repeated echocardiographic evaluation after acute myocardial infarction
539
Prognostic Usefulness of Serial C-Reactive Protein Measurements in ST-Elevation Acute Myocardial Infarction
540
Prognostic Usefulness of Serum Uric Acid After Acute Myocardial Infarction (The Japanese Acute Coronary Syndrome Study)
541
Prognostic Usefulness of the Change in N-terminal pro B-type Natriuretic Peptide Levels to Predict Mortality in a Single Community Cohort Aged ≥70 Years
542
Prognostic usefulness of the six-minute walk in patients with advanced congestive heart failure secondary to ischemic or nonischemic cardiomyopathy
543
Prognostic usefulness of the tricuspid annular plane systolic excursion in patients with congestive heart failure secondary to idiopathic or ischemic dilated cardiomyopathy
544
Prognostic usefulness of white blood cell count and temperature in acute myocardial infarction (from the CARDINAL Trial)
545
Prognostic Usefulness of White Blood Cell Count on Admission and One-Year Outcome in Patients With Non–ST-Segment Elevation Acute Chest Pain
546
Prognostic utility of a semiquantitative spinal deformity index
547
Prognostic Utility of BCIS Myocardial Jeopardy Score for Classification of Coronary Disease Burden and Completeness of Revascularization
548
Prognostic Utility of B-Type Natriuretic Peptide Assessment in Stable Low-Risk Outpatients With Nonischemic Cardiomyopathy After Decompensated Heart Failure Original Research Article
549
Prognostic utility of CD184 in acute myeloid leukemia
550
Prognostic utility of comparative methods for assessment of ST-segment resolution after primary angioplasty for acute myocardial infarction: The controlled abciximab and device investigation to lower late angioplasty complications (CADILLAC) trial Origin
551
Prognostic Utility of Growth Differentiation Factor-15 in Patients With Chronic Heart Failure Original Research Article
552
Prognostic Utility of Left Ventricular End-Diastolic Pressure in Patients with ST-Segment Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention
553
Prognostic Utility of Metabolic Exercise Testing in Minimally Symptomatic Patients With Obstructive Hypertrophic Cardiomyopathy
554
Prognostic Utility of Microvolt T-Wave Alternans in Risk Stratification of Patients With Ischemic Cardiomyopathy Original Research Article
555
Prognostic utility of myocardial blood flow assessed by N-13 ammonia positron emission tomography in patients with idiopathic dilated cardiomyopathy
556
Prognostic utility of myocardial viability assessment
557
Prognostic Utility of Neutrophil Gelatinase-Associated Lipocalin in Predicting Mortality and Cardiovascular Events in Patients With ST-Segment Elevation Myocardial Infarction Treated With Primary Percutaneous Coronary Intervention
558
Prognostic utility of single-photon emission computed tomography in adult patients with hypertrophic cardiomyopathy
559
Prognostic Utility of the Combination of Platelet Count with Neutrophil-to-Lymphocyte Ratio in Aged Patients with Acute Myocardial Infarction Undergoing Percutaneous Coronary Intervention
560
Prognostic Utility of the SYNTAX Score in Patients With Single Versus Multivessel Disease Undergoing Percutaneous Coronary Intervention (from the Acute Catheterization and Urgent Intervention Triage StrategY [ACUITY] Trial)
561
Prognostic Validity of Red Cell Distribution Width in Neonatal Sepsis
562
Prognostic Value and Echocardiographic Determinants of Plasma Myeloperoxidase Levels in Chronic Heart Failure Original Research Article
563
Prognostic Value of New Electrocardiographic Method for Diagnosis of Left Ventricular Hypertrophy in Essential Hypertension
564
Prognostic value of “high normal” serum creatinine in patients with essential hypertension
565
Prognostic Value of 18F-Fluorocholine PET Parameters in Metastatic Castrate-Resistant Prostate Cancer Patients Treated with Docetaxel
566
Prognostic value of 24-hour ambulatory blood pressure measurement for the onset of atrial fibrillation in treated patients with essential hypertension
567
Prognostic value of 2D echocardiography in patients presenting with acute chest pain and non-diagnostic ECG for ST-elevation myocardial infarction
568
Prognostic Value of 2-Deoxy-2-[18F]fluoro-D-glucose Positron Emission Tomography/Computed Tomography after Autologous Hematopoietic Stem Cell Transplantation in Lymphoma Using Deauville Scores
569
Prognostic Value of 64-Slice Cardiac Computed Tomography: Severity of Coronary Artery Disease, Coronary Atherosclerosis, and Left Ventricular Ejection Fraction
570
Prognostic value of a doppler index combining systolic and diastolic performance in idiopathic-dilated cardiomyopathy
571
Prognostic Value of a High On-Clopidogrel Treatment Platelet Reactivity in Bivalirudin Versus Abciximab Treated Non–ST-Segment Elevation Myocardial Infarction Patients: ISAR-REACT 4 (Intracoronary Stenting and Antithrombotic Regimen: Rapid Early Action fo
572
Prognostic Value of a Multimarker Approach for Patients Presenting to Hospital With Acute Chest Pain
573
Prognostic Value of a Multiparametric Risk Score in Patients Undergoing Dipyridamole Stress Echocardiography
574
Prognostic value of a negative stress echocardiographic study in diabetic patients
575
Prognostic Value of a Nine-Minute Treadmill Test in Patients Undergoing Myocardial Perfusion Scintigraphy
576
Prognostic Value of a Restrictive Mitral Filling Pattern in Patients With Systolic Heart Failure and an Implantable Cardioverter-Defibrillator
577
Prognostic value of absolute versus relative measures of the procedural result after successful coronary stenting: Importance of vessel size in predicting long-term freedom from target vessel revascularization
578
Prognostic Value of Adenosine Cardiac Magnetic Resonance Imaging in Patients Presenting With Chest Pain
579
Prognostic Value of Admission Fasting Glucose Levels in Patients With Acute Coronary Syndrome
580
Prognostic value of admission glucose in non-diabetic patients with myocardial infarction
581
Prognostic Value of Admission Hemoglobin Levels in ST-Segment Elevation Myocardial Infarction Patients Presenting With Cardiogenic Shock
582
Prognostic Value of Admission Myeloperoxidase Levels in Patients With ST-Segment Elevation Myocardial Infarction and Cardiogenic Shock
583
Prognostic Value of Admission Neutrophil Count in Asthma Patients with COVID-19: A Comparative Analysis with other Systemic Inflammation Indices for In-Hospital Mortality Prediction
584
Prognostic Value of Admission-to-Discharge Change in Integral Congestion Assessment for Predicting Adverse Outcomes in Patients with Decompensated Heart Failure
585
Prognostic value of ambulatory blood pressure monitoring in refractory hypertension
586
Prognostic Value of Ambulatory Measurement of the Timing of Korotkoff Sounds in Elderly Hypertensives: A Pilot Study
587
Prognostic Value of an Abnormal Ankle–Brachial Index in Patients Receiving Drug-Eluting Stents
588
Prognostic value of an abnormal signal-averaged electrocardiogram in patients with nonischemic dilated cardiomyopathy
589
Prognostic Value of an Exaggerated Exercise Blood Pressure Response in Patients With Diabetes Mellitus and Known or Suspected Coronary Artery Disease
590
Prognostic Value of Anatomical Dominance of Coronary Circulation in Patients with Surgical Myocardial Revascularization
591
Prognostic Value of Androgen Receptor Expression in Bladder Tumors
592
Prognostic Value of Androgen Receptor in Triple Negative Breast Cancer of Iranian Patients in Yazd Region
593
Prognostic value of anemia in predicting sudden death of patients with diastolic heart failure
594
Prognostic Value of Angiographic Lesion Complexity in Patients With Acute Coronary Syndromes Undergoing Percutaneous Coronary Intervention (from the Acute Catheterization and Urgent Intervention Triage Strategy Trial)
595
Prognostic Value of Aortic and Mitral Valve Calcium Detected by Contrast Cardiac Computed Tomography Angiography in Patients With Suspicion of Coronary Artery Disease
596
Prognostic Value of Aortic Valve Area Index in Asymptomatic Patients With Severe Aortic Stenosis
597
Prognostic Value of Aquaporin-3, Vimentin and E-cadherin Expressions in Invasive Breast Carcinoma: An Immunohistochemical Study
598
Prognostic Value of Arterial Blood Gas Indices Regarding the Severity of Traumatic Injury and Fractures of the Femur and Pelvis
599
Prognostic Value of Automatically Detected Early Repolarization
600
Prognostic Value of BAALC Expression in Pediatric Acute Myeloid Leukemia: A Systematic Review
601
Prognostic value of baseline electrophysiology studies in patients with sustained ventricular tachyarrhythmia: The Antiarrhythmics Versus Implantable Defibrillators (AVID) trial
602
Prognostic Value of Blood Pressure Responsiveness in Hemodialysis for Cardiovascular Mortality, Development of A New Predictive Equation
603
Prognostic Value of Brachial Artery Endothelial Function and Wall Thickness Original Research Article
604
Prognostic value of bronchiolo-alveolar carcinoma component of small lung adenocarcinoma
605
Prognostic Value of B-type Natriuretic Peptide for Assessment of Left Ventricular Function in Patients With Chronic Kidney Disease
606
Prognostic Value of B-type Natriuretic Peptide in Patients with Acute Coronary Syndromes
607
Prognostic Value of B-Type Natriuretic Peptides in Patients With Stable Coronary Artery Disease: The PEACE Trial Original Research Article
608
Prognostic value of carbonic anhydrase IX expression in penile squamous cell carcinoma: A pilot study
609
Prognostic value of carbonic anhydrase IX expression in penile squamous cell carcinoma: A pilot study
610
Prognostic value of cardiac autonomic neuropathy independent and incremental to perfusion defects in patients with diabetes and suspected coronary artery disease
611
Prognostic Value of Cardiac Biomarkers and Tissue Doppler Echocardiography to Septic Shock Mortality
612
Prognostic Value of Cardiac Computed Tomography Angiography
613
Prognostic Value of Cardiac Computed Tomography Angiography: A Systematic Review and Meta-Analysis
614
Prognostic Value of Cardiac Troponin I and Left Ventricular Geometry in Pediatric Chronic Hemodialysis: A One Year Follow Up Study
615
Prognostic Value of Cardiac Troponin I Measured With a Highly Sensitive Assay in Patients With Stable Coronary Artery Disease
616
Prognostic Value of Cardiac Troponin T After Noncardiac Surgery: 6-Month Follow-Up Dat
617
Prognostic value of cardiac troponin T in unstable angina pectoris
618
Prognostic value of cardiac troponin-I levels following catheter-based coronary interventions
619
Prognostic value of cardiopulmonary exercise testing using percent achieved of predicted peak oxygen uptake for patients with ischemic and dilated cardiomyopathy
620
Prognostic Value of Cardiopulmonary Exercise Variables in Chronic Heart Failure Patients With or Without Beta-Blocker Therapy
621
Prognostic value of carotid intima-media thickness
622
Prognostic Value of CD44 and HER2/Neu in Invasive Transitional Cell Carcinoma of the Urinary Bladder
623
Prognostic value of CD44 in renal cell carcinoma
624
Prognostic value of cell-cycle regulators and cellular biomarkers in laryngeal squamous cell carcinoma
625
Prognostic Value of Changes in N-Terminal Pro-Brain Natriuretic Peptide in Val-HeFT (Valsartan Heart Failure Trial)
626
Prognostic value of chemokine CCL3 cellular mRNA expression and serum CCL3 level in lymphoma patients
627
Prognostic Value of Chronic Kidney Disease After Transcatheter Aortic Valve Implantation
628
Prognostic value of clinical markers of reperfusion in patients with acute myocardial infarction treated by thrombolytic therapy,
629
Prognostic value of clinical signs and blood parameters in equids suffering from hepatic diseases
630
Prognostic Value of Combined Perfusion and Function by Stress Technetium-99m Sestamibi Gated SPECT Myocardial Perfusion Imaging in Patients With Suspected or Known Coronary Artery Disease
631
Prognostic Value of Computed Tomography Texture Features in Patients with Hepatocellular Carcinoma Following Stereotactic Ablative Radiotherapy
632
Prognostic Value of Concomitant Bronchiectasis in Newly Diagnosed Diffuse Panbronchiolitis Patients on a Maintenance Therapy with Macrolides
633
Prognostic value of congestive heart failure history in patients undergoing percutaneous coronary interventions
634
Prognostic value of copeptin in patients with acute ischemic stroke
635
Prognostic value of coronary artery calcium screening in subjects with and without diabetes Original Research Article
636
Prognostic value of coronary blood flow velocity and myocardial perfusion in intermediate coronary narrowings and multivessel disease
637
Prognostic value of coronary calcification and angiographic stenoses in patients undergoing coronary angiography
638
Prognostic Value of Coronary Computed Tomographic Angiography in Asymptomatic Patients
639
Prognostic value of coronary electron-beam computed tomography for coronary heart disease events in asymptomatic populations
640
Prognostic Value of Coronary Flow Reserve in Medically Treated Patients With Left Anterior Descending Coronary Disease With Stenosis 51% to 75% in Diameter
641
Prognostic Value of Coronary Flow Reserve on Long-Term Cardiovascular Outcomes in Patients With Chronic Kidney Disease
642
Prognostic Value of Coronary Magnetic Resonance Angiography for Prediction of Cardiac Events in Patients With Suspected Coronary Artery Disease
643
Prognostic value of corrected QT-interval prolongation in patients with unstable angina pectoris
644
Prognostic Value of Cortisol in Patients with Acute Ischemic Stroke
645
Prognostic Value of CRASH and IMPACT Models for Predicting Mortality and Unfavorable Outcome in Traumatic Brain Injury; a Systematic Review and Meta-Analysis
646
Prognostic value of C-reactive protein and cardiac troponin I in primary percutaneous interventions for ST-elevation myocardial infarction
647
Prognostic Value of C-Reactive Protein as an Inflammatory and N-Terminal Probrain Natriuretic Peptide as a Neurohumoral Marker in Acute Heart Failure (from the Korean Heart Failure Registry)
648
Prognostic value of C-reactive protein in patients with stress induced myocardial ischemia
649
Prognostic value of C-reactive protein levels within six hours after the onset of acute myocardial infarction
650
Prognostic value of cytokeratin-positive cells in the bone marrow and lymph nodes of patients with resected nonsmall cell lung cancer: a multicenter prospective study
651
Prognostic Value of Depression, Anxiety, and Anger in Hospitalized Cardiovascular Disease Patients for Predicting Adverse Cardiac Outcomes
652
Prognostic Value of Dialysis Effluent Leukocyte Count in Children on Peritoneal Dialysis With Peritonitis
653
Prognostic value of diastolic filling parameters derived using a novel image processing technique in patients ≥70 years of age with congestive heart failure
654
Prognostic Value of Diffusion MR Imaging and Clinical-Pathologic Factors in Patients with Rectal Cancer
655
Prognostic value of dipyridamole imaging in patients with left bundle branch block: review of 96 patients
656
Prognostic Value of Dipyridamole Stress Cardiovascular Magnetic Resonance Imaging in Patients With Known or Suspected Coronary Artery Disease Original Research Article
657
Prognostic value of DNA ploidy response to chemotherapy in human osteosarcomas
658
Prognostic Value of Dobutamine Echocardiography Early After Uncomplicated Acute Myocardial Infarction: Comparison With Exercise Electrocardiography
659
Prognostic value of dobutamine echocardiography in patients after q-wave or non–q-wave acute myocardial infarction
660
Prognostic value of dobutamine echocardiography in patients with left ventricular dysfunction
661
Prognostic value of dobutamine stress echocardiography in patients referred because of suspected coronary artery disease
662
Prognostic Value of Dobutamine Stress Echocardiography in Patients Undergoing Diagnostic Coronary Arteriography
663
Prognostic value of dobutamine stress echocardiography in patients with chronic kidney disease
664
Prognostic value of dobutamine stress echocardiography in patients with systemic hypertension and known or suspected coronary artery disease
665
Prognostic value of dobutamine stress echocardiography in predicting cardiac events in patients with known or suspected coronary artery disease
666
Prognostic Value of Dobutamine Stress Echocardiography With Early Injection of Atropine With Versus Without Chronic Beta-Blocker Therapy in Patients With Known or Suspected Coronary Heart Disease
667
Prognostic value of dobutamine stress technetium-99m-sestamibi single-photon emission computed tomography myocardial perfusion imaging: stratification of a high-risk population
668
Prognostic value of dobutamine-atropine sestamibi imaging
669
Prognostic Value of Dobutamine–Atropine Stress Echocardiography Early After Acute Myocardial Infarction
670
Prognostic value of dobutamine-atropine stress technetium-99m sestamibi perfusion scintigraphy in patients with chest pain
671
Prognostic value of Doppler echocardiographic mitral inflow patterns: implications for risk stratification in patients with chronic congestive heart failure
672
Prognostic Value of Doppler Transmitral Flow Velocity Patterns in Acute Myocardial Infarction
673
Prognostic value of doppler ultrasound findings in patients with middle cerebral artery Ischemic stroke
674
Prognostic value of Doppler-derived myocardial performance index in patients with left ventricular systolic dysfunction
675
Prognostic Value of Early Acute Kidney Injury After Primary Percutaneous Coronary Intervention in Patients With ST-Segment Elevation Myocardial Infarction
676
Prognostic Value of Early Exercise Testing After Coronary Stent Implantation
677
Prognostic Value of Early Exercise Testing After Coronary Stent Implantation: A Strategy of Routine Stress Testing After Percutaneous Coronary Intervention Is Not of Proven Benefit
678
Prognostic Value of Early Introduction of Second Line in Patients with Diffuse Large B Cell Lymphoma
679
Prognostic value of E-cadherin expression in thyroid follicular carcinoma
680
Prognostic value of EGF receptor and tumor cell proliferation in bladder cancer: therapeutic implications
681
Prognostic value of electrocardiograms, ventricular late potentials, ventricular arrhythmias, and left ventricular systolic dysfunction in patients with Duchenne muscular dystrophy
682
Prognostic value of electrocardiographic criteria for left ventricular hypertrophy
683
Prognostic Value of Electrocardiographic Measurements Before and After Cardiac Resynchronization Device Implantation in Patients With Heart Failure due to Ischemic or Nonischemic Cardiomyopathy
684
Prognostic value of electroencephalography pattern in prediction of survival and early myoclonus after cardiac arrest
685
Prognostic value of electrophysiologic studies in brugada syndrome
686
Prognostic Value of Elevated Levels of Intestinal Microbe-Generated Metabolite Trimethylamine-N-Oxide in Patients With Heart Failure: Refining the Gut Hypothesis
687
Prognostic Value of Elevated SHIP2 Expression in Laryngeal Squamous Cell Carcinoma
688
Prognostic Value of Elevated White Blood Cell Count in Hypertension
689
Prognostic value of endocardial electromechanical mapping in patients with left ventricular dysfunction undergoing percutaneous coronary intervention
690
Prognostic value of endothelial function
691
Prognostic value of end-tidal carbon dioxide during exercise testing in heart failure
692
Prognostic Value Of End-Tidal Carbon Dioxide Pressures During Out-Of-Hospital Cardiac Arrest, ,
693
Prognostic value of energy metabolism in patients with viral liver cirrhosis
694
Prognostic Value of Epithelial Mesenchymal Transition (EMT Slug) Markers in Ductal Carcinoma of the Breast
695
Prognostic Value of EVI1 Expression in Pediatric Acute Myeloid Leukemia: A Systematic Review
696
Prognostic value of exercise cardiac tomography performed late after percutaneous coronary intervention in symptomatic and symptom-free patients
697
Prognostic value of exercise echocardiography in 2,632 patients ≥65 years of age
698
Prognostic value of exercise echocardiography in patients after coronary artery bypass surgery
699
Prognostic value of exercise echocardiography in patients with classic angina pectoris
700
Prognostic Value of Exercise Echocardiography in Patients With Diabetes Mellitus and Known or Suspected Coronary Artery Disease
701
Prognostic value of exercise echocardiography in women in the community setting
702
Prognostic value of exercise echocardiographyin 5,798 patients: is there a gender difference?
703
Prognostic value of exercise stress myocardial perfusion imaging in patients with permanent pacemakers
704
Prognostic Value of Exercise Stress Technetium-99m-Tetrofosmin Myocardial Perfusion Imaging in Patients With Normal Baseline Electrocardiograms
705
Prognostic value of exercise testing in women after acute coronary syndromes (the Stockholm female coronary risk study)
706
Prognostic value of exercise thallium-201 imaging in a community population, , ,
707
Prognostic Value of Exercise Thallium-201 Imaging Performed Within 2 Years of Coronary Artery Bypass Graft Surgery
708
Prognostic Value of Exercise Tolerance Testing in Asymptomatic Chronic Nonischemic Mitral Regurgitation
709
Prognostic Value of f3-Catenin and S100A4 in Colorectal Carcinoma
710
Prognostic Value of FDG-PET, Based on the Revised Response Criteria, in Patients with Malignant Lymphoma: A Comparison with CT/MRI Evaluations, Based on the International Working Group/ Cotswolds Meeting Criteria
711
Prognostic value of fluorine-18-deoxyglucose (FDG) positron emission tomograpy (PET) in neuroendocrine tumors (NETs)
712
Prognostic value of FOXP3 and TGF-β expression in both peripheral blood and lymph nodes in patients with B-Non Hodgkin’s lymphoma
713
Prognostic Value of Fractional Flow Reserve: Linking Physiologic Severity to Clinical Outcomes
714
Prognostic value of fragmented QRS on a 12-lead ECG in patients with acute myocardial infarction
715
Prognostic Value of Free Plasma Homocysteine Levels in Patients Hospitalized With Acute Coronary Syndrome
716
Prognostic Value of Frontal QRS-T Angle in Patients Without Clinical Evidence of Cardiovascular Disease (from the Multi-Ethnic Study of Atherosclerosis)
717
Prognostic Value of Functional Parameters of 18F-FDG-PET Images in Patients with Primary Renal/Adrenal Lymphoma
718
Prognostic Value of Functional Performance for Mortality in Patients With Peripheral Artery Disease Original Research Article
719
Prognostic value of heart rate adjustment of exercise-induced ST segment depression in the multiple risk factor intervention trial
720
Prognostic value of heart rate recovery in patients with heart failure
721
Prognostic Value of Heart Rate Turbulence and Its Relation to Inflammation in Patients With Unstable Angina Pectoris
722
Prognostic value of heart rate variability during long-term follow-up in patients with mild to moderate heart failure
723
Prognostic value of heart rate variability for sudden death and major arrhythmic events in patients with idiopathic dilated cardiomyopathy
724
Prognostic Value of Heart Rate Variability in Chronic Congestive Heart Failure Secondary to Idiopathic or Ischemic Dilated Cardiomyopathy
725
Prognostic value of heart rate variability in idiopathic dilated cardiomyopathy
726
Prognostic Value of Heart-Type Fatty Acid Binding Protein in Patients with Acute Coronary Syndrome
727
Prognostic value of hemodynamic findings from impedance cardiography in hypertensive stroke
728
Prognostic value of hemoglobin A1c in nondiabetic and diabetic patients with acute ischemic stroke
729
Prognostic Value of Hemoglobin A1C Levels in Patients With Diabetes Mellitus Undergoing Percutaneous Coronary Intervention With Stent Implantation
730
Prognostic value of hemostasis-related parameters for prediction of organ dysfunction and mortality in sepsis
731
Prognostic value of hepatocyte growth factor in dialysis patients with heart failure
732
Prognostic value of hepatocyte growth factor in haemophagocytic lymphohistiocytosis
733
Prognostic value of HER-2/neu and p53 expression in node-positive breast cancer. HER-2/neu effect on adjuvant tamoxifen treatment
734
Prognostic value of HER2/neu expression in patients with prostate cancer: a systematic review
735
Prognostic value of high dose dipyridamole echocardiography in patients with chronic coronary artery disease and preserved left ventricular function
736
Prognostic value of high on-treatment platelet reactivity
737
Prognostic value of high plasma brain natriuretic peptide concentrations in very elderly persons
738
Prognostic Value of High-Dose Dobutamine Stress Magnetic Resonance Imaging in 1,493 Consecutive Patients: Assessment of Myocardial Wall Motion and Perfusion
739
Prognostic Value of Histology in Resected Lung Cancer With Emphasis on the Relevance of the Adenocarcinoma Subtyping
740
Prognostic Value of HLA-G in Malignant Liver and Pancreas Lesions
741
Prognostic value of home heart rate for cardiovascular mortality in the general population: The Ohasama study
742
Prognostic value of HPV DNA in Urothelial Carcinoma of the Bladder: A Preliminary Report of 2-Year Follow-up Results
743
Prognostic value of human erythrocyte acetyl cholinesterase in acute organophosphate poisoning
744
Prognostic value of ictal onset patterns in postsurgical outcome of temporal lobe epilepsy
745
Prognostic Value of Immune Checkpoints in Prostate Cancer: A Systematic Review and Meta-Analysis of Reconstructed Time to Event Data
746
Prognostic value of immunofluorometrically quantifed P53 protein in ovarian carcinoma
747
Prognostic value of immunofluorometrically quantifed P53 protein in ovarian carcinoma
748
Prognostic value of immunohistochemically detected HER-2/neu oncoprotein in endometrial cancer
749
Prognostic Value of IMP3 and Cyclin D1 Expression in Patients with Colorectal Cancer
750
Prognostic Value of Impaired Fasting Glucose for Outcomes of Patients With Stable Angina Pectoris Treated With Percutaneous Coronary Interventions
751
Prognostic Value of Impaired Preoperative Ankle Reflex in Surgical Outcome of Lumbar Disc Herniation
752
Prognostic Value of Impaired Preoperative Ankle Reflex in Surgical Outcome of Lumbar Disc Herniation
753
Prognostic value of infection and inflammation markers for late cardiac events in an Iranian sample
754
Prognostic value of inflammatory biomarkers for predicting the extent of lung involvement and final clinical outcome in patients with COVID‑19
755
Prognostic value of insulin- like growth factor-I receptor expression in renal cell carcinoma
756
Prognostic value of insulin-like growth factor-1 receptors in patients with colon/rectal cancer: Correlation with plasma prolactin
757
Prognostic value of intensive care scores concerning the prediction of 30-day mortality in COVID-19
758
Prognostic value of interleukin-1 receptor antagonist in patients undergoing percutaneous coronary intervention
759
Prognostic Value of Interleukin-6 (IL-6) and Tumor Necrosis Factor-Alpha (TNF-α) in Egyptian Patients with Breast Cancer
760
Prognostic value of interleukin-8 as a predictor of heart failure in patients with myocardial infarction and percutaneous intervention
761
Prognostic Value of Interlukine-1 Receptor Antagonist and Tumor Necrosis Factor Gene Polymorphism in Systemic Inflammatory Response Syndrome
762
Prognostic Value of Intracellular Transcription of Factors HIF-1α and p53 and Their Relation to Estradiol and TNM Parameters of Breast Cancer Tissues in Women with Invasive Ductal Carcinoma in Thi-Qar Province, Iraq
763
Prognostic Value of Intraventricular Dyssynchrony According to Clinical Stage of Left Ventricular Impairment
764
Prognostic Value of Iodine-123-Metaiodobenzylguanidine Myocardial Uptake and Heart Rate Variability in Chronic Congestive Heart Failure Secondary to Ischemic or Idiopathic Dilated Cardiomyopathy
765
Prognostic value of ischemic electrocardiographic findings for cardiovascular mortality in men and women
766
Prognostic value of isolated troponin elevation across the spectrum of chest pain syndromes
767
Prognostic Value of KI6 Biomarker in Predict Short Time Prognosis of Low Grade Cervical Intraepithelial Neoplasia in HPV Negative and Positive Patients
768
Prognostic Value of KI6 Biomarker to Predict Short Term Prognosis of Low Grade Cervical Intraepithelial Neoplasia in Human Papilloma Virus Negative and Positive Patients
769
Prognostic Value of Late Heart Rate Recovery After Treadmill Exercise
770
Prognostic value of left atrial enlargement in patients with idiopathic dilated cardiomyopathy and ischemic cardiomyopathy
771
Prognostic value of left ventricular apical tissue removed for HeartMate II left ventricular assist device placement
772
Prognostic value of left ventricular concentric remodeling in uncomplicated mild hypertension
773
Prognostic value of left ventricular dyssynchrony in patients with heart failure
774
Prognostic value of left ventricular dyssynchrony in patients with heart failure: Reply
775
Prognostic value of left ventricular hypertrophy and geometry in patients with a first, uncomplicated myocardial infarction
776
Prognostic value of left ventricular mass and geometry in systemic hypertension with left ventricular hypertrophy
777
Prognostic value of left ventricular mass and its evolution during treatment in the bordeaux cohort of hypertensive patients
778
Prognostic Value of Left Ventricular Myocardial Performance Index in Patients Undergoing Coronary Artery Bypass Graft Surgery
779
Prognostic Value of Lesion Classification for the Clinical Outcome After Stent Placement
780
Prognostic value of lipoproteins and their relation to inflammatory markers among patients with coronary artery disease
781
Prognostic Value of Location and Type of Myocardial Infarction in the Setting of Advanced Left Ventricular Dysfunction
782
Prognostic Value of Low Blood Glucose at the Presentation of E. coli Bacteremia
783
Prognostic value of low-level cardiac troponin-I elevations in patients without definite acute coronary syndromes
784
Prognostic Value of Lung Sestamibi Uptake in Myocardial Perfusion Imaging of Patients With Known or Suspected Coronary Artery Disease Original Research Article
785
Prognostic Value of Lymph Node Ratio in comparison to Lymph Node Metastases in Stage III Colon Cancer
786
Prognostic value of lymphocytes counts, serum CRP levels, and lung CT scan findings and the final disease outcome in COVID-19
787
Prognostic value of magnetic resonance spectroscopy in patients with diffuse axonal injury: a systematic literature review
788
Prognostic value of mean platelet volume in patients undergoing elective percutaneous coronary intervention
789
Prognostic value of mechanical efficiency in ambulatory patients with idiopathic dilated cardiomyopathy in sinus rhythm
790
Prognostic value of mental stress testing in coronary artery disease
791
Prognostic Value of Midregional Pro-Adrenomedullin in Patients With Acute Myocardial Infarction: The LAMP (Leicester Acute Myocardial Infarction Peptide) Study Original Research Article
792
Prognostic Value of Mid-Regional Pro-Adrenomedullin Levels Taken on Admission and Discharge in Non–ST-Elevation Myocardial Infarction: The LAMP (Leicester Acute Myocardial Infarction Peptide) II Study
793
Prognostic value of minimal residual disease in acute lymphoblastic leukaemia in childhood
794
Prognostic value of minimal residual disease in acute lymphoblastic leukaemia in childhood
795
Prognostic value of minimal residual disease in relapsed childhood acute lymphoblastic leukaemia
796
Prognostic value of mitotic counts in axillary node negative breast cancer patients with predominantly well-differentiated tumours
797
Prognostic Value of Monocyte Count in Patients Hospitalized for Heart Failure With Reduced Ejection Fraction (from the EVEREST Trial)
798
Prognostic Value of Multidetector Coronary Computed Tomographic Angiography for Prediction of All-Cause Mortality Original Research Article
799
Prognostic Value of Multidetector Coronary Computed Tomography Angiography
800
Prognostic Value of Multidetector Coronary Computed Tomography Angiography in Relation to Exercise Electrocardiogram in Patients With Suspected Coronary Artery Disease
801
Prognostic Value of Multiple Biomarkers in American Indians Free of Clinically Overt Cardiovascular Disease (from the Strong Heart Study)
802
Prognostic Value of Multislice Computed Tomography and Gated Single-Photon Emission Computed Tomography in Patients With Suspected Coronary Artery Disease
803
Prognostic Value of Multislice Computed Tomography Coronary Angiography in Patients With Known or Suspected Coronary Artery Disease Original Research Article
804
Prognostic value of mutations and a germ line polymorphism of the p53 gene in non-small cell lung carcinoma: association with clinicopathological features
805
Prognostic value of myeloperoxidase in patients with chest pain
806
Prognostic Value of Myocardial Contrast Delayed Enhancement With 64-Slice Multidetector Computed Tomography After Acute Myocardial Infarction
807
Prognostic Value of Myocardial Contrast Echocardiography in Patients Presenting to Hospital With Acute Chest Pain and Negative Troponin
808
Prognostic Value of Myocardial Infarct Size and Contractile Reserve Using Magnetic Resonance Imaging
809
Prognostic Value of Myocardial Injury Following Transcatheter Aortic Valve Implantation
810
Prognostic Value of Myocardial Ischemic Electrocardiographic Response in Patients With Normal Stress Echocardiographic Study
811
Prognostic value of myocardial perfusion imaging in predicting outcome after renal transplantation
812
Prognostic Value of Myocardial Scar in Atrial Fibrillation
813
Prognostic value of myocardial viability and ischemi detected by dobutamine stress echocardiography early after acute myocardial infarction treated with thrombolysis
814
Prognostic Value of Myocardial Viability by Delayed-Enhanced Magnetic Resonance in Patients With Coronary Artery Disease and Low Ejection Fraction: Impact of Revascularization Therapy
815
Prognostic Value of Myocardial Viability Detected by Myocardial Contrast Echocardiography Early After Acute Myocardial Infarction Original Research Article
816
Prognostic value of myocardial viability recognized by low-dose dobutamine echocardiography in chronic ischemic left ventricular dysfunction
817
Prognostic value of negative dobutamine stress echo in women with intermediate probability of coronary artery disease
818
Prognostic value of negative transesophageal dobutamine stress echocardiography in men at high risk for coronary artery disease
819
Prognostic value of neopterin levels in treated patients with hypertension and chest pain but without obstructive coronary artery disease
820
Prognostic value of neurohormonal activation and cardiopulmonary exercise testing in patients with chronic heart failure
821
Prognostic Value of Neutrophil to Lymphocyte Ratio in Patients Presenting With ST-Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention
822
Prognostic Value of Neutrophil to Lymphocyte Ratio on Pathologic Findings of Transrectal Ultrasonography Guided Biopsy of Prostate
823
Prognostic value of neutrophil/lymphocyte ratio in patients with pulmonary embolism
824
Prognostic Value of Nocturnal Melatonin Levels as a Novel Marker in Patients With ST-Segment Elevation Myocardial Infarction
825
Prognostic value of nodal micrometastases in patients with cancer of the gastro-oesophageal junction
826
Prognostic value of noninvasive testing one year after orthotopic cardiac transplantation
827
Prognostic Value of Noninvasively Obtained Left Ventricular Contractile Reserve in Patients With Severe Heart Failure
828
Prognostic Value of Normal Adenosine-Stress Cardiac Magnetic Resonance Imaging
829
Prognostic value of normal and non-obstructive coronary artery disease based on CT angiography findings. A 12 month follow up study
830
Prognostic Value of Normal Exercise Echocardiography in a One-Year Follow-up
831
Prognostic value of normal exercise Tc-99m Sestamibi myocardial perfusion imaging in Karachi, Pakistan
832
Prognostic value of normal stress echocardiogram in patients with suspected coronary artery disease—A British general hospital experience
833
Prognostic value of N-terminal pro-atrial and pro-brain natriuretic peptide in patients with acute coronary syndromes
834
Prognostic value of N-terminal proatrial natriuretic factor plasm levels measured within the first 12 hours after myocardial infarction
835
Prognostic Value of N-Terminal Pro-Brain Natriuretic Peptide in Outpatients With Hypertrophic Cardiomyopathy
836
Prognostic Value of N-Terminal Pro-B-Type Natriuretic Peptide in Patients With Active Infective Endocarditis
837
Prognostic value of N-terminal pro-B-type natriuretic peptide, cytokines and sCD40L in patients with acute heart failure  
838
Prognostic Value of N-Terminal Pro–Type-B Natriuretic Peptide and Doppler Left Ventricular Diastolic Variables in Patients With Chronic Systolic Heart Failure Stabilized by Therapy
839
Prognostic value of nucleolar organizer regions in supraglottic carcinoma
840
Prognostic value of osteoprotegerin in heart failure after acute myocardial infarction Original Research Article
841
Prognostic value of overexpression of p53 in human ovarian carcinoma patients receiving cisplatin
842
Prognostic value of p53 and MIB-1 in transitional cell carcinoma of the urinary bladder with regional lymph node involvement: Frank I, Cheville JC, Blute ML, Lohse CM, Karnes RJ, Weaver AL, Sebo TJ, Nehra A, Zincke H, Department of Urology, Mayo Clinic, R
843
Prognostic value of p53 in renal cell carcinoma
844
Prognostic Value of P63, Maspin, and MMP-2 Expression in Salivary Gland Adenoid Cystic Carcinoma
845
Prognostic Value of Pacing-Induced Mechanical Alternans in Patients With Mild-to-Moderate Idiopathic Dilated Cardiomyopathy in Sinus Rhythm Original Research Article
846
Prognostic value of peak exercise systolic blood pressure on long-term survival after myocardial infarction
847
Prognostic value of pentraxin 3 in patients with chronic heart failure
848
PROGNOSTIC VALUE OF P-GLYCOPROTEIN EXPRESSION AND BCL-2/BAX RATIO IN AML PATIENTS
849
Prognostic value of pharmacologic stress echocardiography in patients with left bundle branch block
850
Prognostic Value of Pharmacological Stress Echocardiography in Diabetic and Nondiabetic Patients With Known or Suspected Coronary Artery Disease Original Research Article
851
Prognostic value of pharmacological stress echocardiography in women with chest pain and unknown coronary artery disease
852
Prognostic Value of Plasma Brain Natriuretic Peptide, Urea Nitrogen, and Creatinine in Outpatients >70 Years of Age With Heart Failure
853
Prognostic value of plasma chromogranin A levels in patients with complicated myocardial infarction
854
Prognostic value of plasma erythropoietin on mortality in patients with chronic heart failure Original Research Article
855
Prognostic value of plasma fibrinogen concentration in patients with unstable angina and non-Q-wave myocardial infarction (TIMI IIIB Trial)
856
Prognostic Value of Plasma Fibrinolysis Activation Markers in Cardiovascular Disease
857
Prognostic Value of Plasma Ghrelin in Predicting the Outcome of Patients with Chronic Heart Failure
858
Prognostic value of plasma interleukin-6 concentrations and the −174 G > C and −572 G > C promoter polymorphisms of the interleukin-6 gene in patients with acute myocardial infarction treated with thrombolysis
859
Prognostic value of plasma levels of secretory type II phospholipase A2 in patients with unstable angina pectoris
860
Prognostic Value of Plasma Markers of Immune Activation in Patients with Advanced HIV Disease Treated by Combination Antiretroviral Therapy
861
Prognostic Value of Plasma Renin Activity in Heart Failure
862
Prognostic value of plasma soluble intercellular adhesion molecule-1 and endothelin-1 concentration in patients with chronic congestive heart failure
863
Prognostic value of plasma ST2 in patients with non-ST segment elevation acute coronary syndrome
864
Prognostic Value of Platelet Counts in Patients with Metastatic Prostate Cancer Treated with Endocrine Therapy
865
Prognostic Value of Platelet Counts in Patients with Metastatic Prostate Cancer Treated with Endocrine Therapy
866
Prognostic value of platelet indices in patients with acute pulmonary thromboembolism
867
Prognostic value of portal haemodynamics
868
Prognostic value of positive pleural lavage in patients with lung cancer resection
869
Prognostic Value of P-POSSUM and Osteopenia for Predicting Mortality After Emergency Laparotomy in Geriatric Patients
870
Prognostic value of predischarge dipyridamole technetium 99m sestamibi myocardial tomography in medically treated patients with unstable angina
871
Prognostic value of predischarge dobutamine stress echocardiography in chest pain patients with a negative cardiac troponin T
872
Prognostic value of predischarge electrocardiographic measurement of infarct size after thrombolysis: Insights from GUSTO I Economics and Quality of Life substudy
873
Prognostic value of predischarge exercise stress echocardiography after acute myocardial infarction
874
Prognostic value of predischarge exercise testing, ejection fraction, and ventricular ectopic activity in acute myocardial infarction treated with streptokinase
875
Prognostic Value of Preoperative Atrial Fibrillation in Patients With Aortic Stenosis and Low Ejection Fraction Having Aortic Valve Replacement
876
PROGNOSTIC VALUE OF PREOPERATIVE SCIATALGIA IN LUMBAR DISC SURGERY
877
Prognostic value of pretreatment FDG PET/CT in uterine cervical cancer according to two major histologic types: squamous cell carcinoma and adenocarcinoma
878
Prognostic value of pretreatment levels of tumor markers for hepatocellular carcinoma on survival after curative treatment of patients with HCC
879
Prognostic Value of Procalcitonin Recovery Level for Malaria Recrudescence
880
Prognostic value of proliferating cell nuclear antigen in Wilms» tumour in children
881
Prognostic value of prominent DCIS component in the breast-conserving therapy of stage I and II invasive ductal breast cancer
882
Prognostic value of prostate specific antigen before, during and after radiotherapy
883
Prognostic value of pseudonormal and restrictive filling patterns on left ventricular remodelingand cardiac events after coronary artery bypass grafting
884
Prognostic value of pulmonary venous flow Doppler signal in left ventricular dysfunction: contribution of the difference in duration of pulmonary venous and mitral flow at atrial contraction
885
Prognostic Value of Pulse-Wave Tissue Doppler Parameters in Patients With Systolic Heart Failure
886
Prognostic Value of QRS Duration After Transcatheter Aortic Valve Implantation for Aortic Stenosis Using the CoreValve
887
Prognostic value of QT dispersion in acute stroke
888
Prognostic value of QT interval and QT dispersion in patients with left ventricular systolic dysfunction: Results from a cohort of 2265 patients with an ejection fraction of ≤40%
889
Prognostic value of quantitative troponin T measurements in unstable angina/non-ST-segment elevation acute myocardial infarction treated early and predominantly with percutaneous coronary intervention
890
Prognostic value of quantitatively assessed KLK7 expression in ovarian cancer
891
Prognostic value of regional cerebral metabolism in patients undergoing dementia evaluation: comparison to a quantifying parameter of subsequent cognitive performance and to prognostic assessment without PET*1
892
Prognostic value of remnant-like lipoprotein particle levels in patients with coronary artery disease and type ii diabetes mellitus Original Research Article
893
Prognostic Value of Renal Dysfunction for the Prediction of Outcome Versus Results of Computed Tomographic Coronary Angiography
894
Prognostic value of renal function in patients with cardiac resynchronization therapy
895
Prognostic Value of Renal Pathological Findings in Children With Atypical Hemolytic Uremic Syndrome
896
Prognostic value of resting end-tidal carbon dioxide in patients with heart failure
897
Prognostic value of resting thallium-201 imaging: Measurement of infarction but not ischemi predicts outcome
898
Prognostic value of rest-redistribution tomographic thallium-201 imaging in ischemic cardiomyopathy
899
Prognostic Value of Right Heart Catheterization Hemodynamic Dat in Surgically Treated Patients with Coronary Artery Disease
900
Prognostic value of right ventricular myocardial performance index in patients undergoing coronary artery bypass surgery
901
Prognostic Value of Routine Biochemistry Profile of Liver Transplant Patients Admitted to the Emergency Department with a Suspected Infection
902
Prognostic Value of Routine Preoperative Electrocardiography in Patients Undergoing Noncardiac Surgery
903
Prognostic Value of Self-Reported Versus Objectively Measured Functional Capacity in Patients With Heart Failure: Results From the TIME-CHF (Trial of Intensified Versus Standard Medical Therapy in Elderly Patients With Congestive Heart Failure)
904
Prognostic value of serial changes in left ventricular mass in essential hypertension
905
Prognostic Value of Serial Electrocardiographic Voltage and Repolarization Changes in Essential Hypertension: The HEART Survey Study
906
Prognostic Value of Serial Global Longitudinal Strain Measured by Two-Dimensional Speckle Tracking Echocardiography in Patients With ST-Segment Elevation Myocardial Infarction
907
Prognostic Value of Serum Albumin at Admission for Neurologic Outcome with Targeted Temperature Management after Cardiac Arrest
908
Prognostic Value of Serum B-Type Natriuretic Peptide in Early Mortality and Morbidity of Children with Congenital Heart Disease after Open Heart Surgery
909
Prognostic value of serum cardiac troponin I in ambulatory patients with chronic renal failure undergoing long-term hemodialysis: A two-year outcome analysis
910
Prognostic value of serum hyaluronan in patients with compensated HCV cirrhosis
911
Prognostic value of serum interleukin-6 (IL-6) levels in long term care
912
Prognostic value of simultaneous perfusion and function assessment using technetium-99m sestamibi
913
Prognostic Value of Site SYNTAX Score and Rationale for Combining Anatomic and Clinical Factors in Decision Making: Insights From the SYNTAX Trial
914
Prognostic Value of Slow Resolution of ST-Segment Elevation Following Successful Direct Percutaneous Transluminal Coronary Angioplasty for Recovery of Left Ventricular Function
915
Prognostic Value of Soluble ST2 (sST2) Serum Level in Congenital Heart Disease Children with Heart Failure
916
Prognostic value of ST segment depression in acute coronary syndromes: insights from PARAGON-A applied to GUSTO-IIb
917
Prognostic value of strain and strain rate in the prediction of postoperative atrial fibrillation in patients undergoing coronary artery bypass grafting: a systematic literature review
918
Prognostic Value of Stress Cardiac Magnetic Resonance Imaging in Patients With Known or Suspected Coronary Artery Disease: A Systematic Review and Meta-Analysis
919
Prognostic value of stress dobutamine technetium-99m sestamibi single-photon emission computed tomography (SPECT) in patients with suspected coronary artery disease
920
Prognostic Value of Stress Echocardiogram in Patients With Angiographically Significant Coronary Artery Disease
921
Prognostic Value of Stress Echocardiography in the Evaluation of Atypical Chest Pain Patients Without Known Coronary Artery Disease
922
Prognostic value of stress-gated Tc-99m sestamibi SPECT after acute myocardial infarction
923
Prognostic Value of ST-T Abnormalities and Left High R Waves With Cardiovascular Mortality in Japanese (24-Year Follow-Up of NIPPON DATA80)
924
Prognostic Value of SYNTAX Scores for Predicting Major Cardiac Adverse Events in Patients with Acute Myocardial Infarction Treated with Primary Percutaneous Coronary Intervention
925
Prognostic value of systemic blood pressure response during exercise in community-based patient population with hypertrophic cardiomyopathy
926
Prognostic value of Th1/Th2 ratio in rheumatoid arthritis
927
Prognostic value of Th1/Th2 ratio in rheumatoid arthritis
928
Prognostic value of Th1/Th2 ratio in rheumatoid arthritis
929
Prognostic value of thallium-201 single-photon emission computed tomography for patients with multivessel coronary artery disease after revascularization (the Emory Angioplasty versus Surgery Trial [EAST])
930
Prognostic value of the admission electrocardiogram in patients with unstable angina/non–ST-segment elevation myocardial infarction treated with very early revascularization
931
Prognostic value of the amount of dysfunctional but viable myocardium in revascularized patients with coronary artery disease and left ventricular dysfunction
932
Prognostic value of the apoptosis related genes BCL2 and BCL2L12 in breast cancer
933
Prognostic value of the biomarker copeptin in critically ill patients with sepsis
934
Prognostic Value of the Duke Treadmill Score in Asymptomatic Women
935
Prognostic value of the Duke Treadmill Score in diabetic patients
936
Prognostic value of the Duke treadmill score in the elderly
937
Prognostic Value of the Expression of Receptor Tyrosine Kinase-Like Orphan Receptor 1 (ROR-1) in Chronic Lymphocytic Leukemia
938
Prognostic value of the galactose test in predicting survival of patients with cirrhosis evaluated for liver transplantation A prospective multicenter Italian study
939
Prognostic value of the high-mobility group box-1 in young patients with chest pain
940
Prognostic Value of The Leuko-Glycemic Index in Acute Myocardial Infarction; a Systematic Review and Meta-Analysis
941
Prognostic value of the metabolic syndrome in essential hypertension Original Research Article
942
Prognostic Value of the Modified American College of Cardiology/American Heart Association Lesion Morphology Classification for Clinical Outcome After Sirolimus-Eluting Stent Placement (Results of the Prospective Multicenter German Cypher Registry)
943
Prognostic Value of the Shock Index Along With Transthoracic Echocardiography in Risk Stratification of Patients With Acute Pulmonary Embolism
944
Prognostic value of the signal-averaged electrocardiogram and a prolonged QRS in ischemic ana nonischemic cardiomyopathy
945
Prognostic value of the soluble interleukin-2 receptor in chronic hepatitis C treated with interferon-alfa
946
Prognostic Value of the SYNTAX Score in Patients With Acute Coronary Syndromes Undergoing Percutaneous Coronary Intervention: Analysis From the ACUITY (Acute Catheterization and Urgent Intervention Triage StrategY) Trial
947
Prognostic value of the VE/VCO2 slope calculated from different time intervals in patients with suspected heart failure
948
Prognostic Value of Thrombolysis, Coronary Artery Patency, Signal-Averaged Electrocardiography, Left Ventricular Ejection Fraction, and Holter Electrocardiographic Monitoring for Life-Threatening Ventricular Arrhythmias After a First Acute Myocardial Infa
949
Prognostic value of tissue Doppler imaging in patients with chronic congestive heart failure
950
Prognostic value of tissue inhibitor of matrix metalloproteinase-1 in plasma of patients with gastric cancer
951
Prognostic Value of Total Bilirubin in Patients With ST-Segment Elevation Acute Myocardial Infarction Undergoing Primary Coronary Intervention
952
Prognostic Value of Total Lymph Node Identified and Ratio of Lymph Nodes in Resected Colorectal Cancer
953
Prognostic Value of Total Lymph Node Identified and Ratio of Lymph Nodes in Resected Colorectal Cancer
954
Prognostic value of TP53 and K-ras-2 mutational analysis in stage III carcinoma of the colon
955
Prognostic value of training-induced change in peak exercise capacity in patients with myocardial infarcts and patients with coronary bypass surgery
956
Prognostic Value of Transient and Sustained Increase in In-Hospital Creatinine on Outcomes of Patients Admitted With Acute Coronary Syndrome
957
Prognostic value of treatment-induced changes in twenty-four-hour mean and pulse pressures in adult hypertensive patients
958
Prognostic Value of Troponin T after Elective Percutaneous Coronary Intervention
959
Prognostic value of tumoral ploidy in a series of Spanish patients with acute lymphoblastic leukemia
960
Prognostic Value of T-Wave Alternans in Patients With Heart Failure Due to Nonischemic Cardiomyopathy: Results of the ALPHA Study Original Research Article
961
Prognostic Value of Uric Acid in Patients With Acute Coronary Syndromes
962
Prognostic Value of Uric Acid in Patients With ST-Elevated Myocardial Infarction Undergoing Primary Coronary Intervention
963
Prognostic value of uterine artery doppler velocimetry in growth-restricted fetuses delivered near term
964
Prognostic value of various metabolic parameters on pre-treatment 18-F-FDG PET/CT in patients with stage I-III non-small cell lung cancer
965
Prognostic value of vascular endothelial growth factor and tumor necrosis factor alfa in myelodysplastic syndrome
966
Prognostic Value of Volume-Based Positron Emission Tomography/Computed Tomography in Nasopharyngeal Carcinoma Patients after Comprehensive Therapy
967
Prognostic Values of Estrogen and Progesterone Expression Receptors in Ovarian Papillary Serous Carcinoma
968
Prognostic Values of Fluctuations in Serum Levels of Alanine Transaminase in Inactive Carrier State of HBV Infection
969
Prognostic values of osteopontin-c, E-cadherin and β-catenin in breast cancer
970
Prognostic Values of Proliferative Markers ki-67 and repp86 in Breast Cancer
971
Prognostic values of urea/lymphocyte and LDH/lymphocyte ratios for predicting mortality in COVID-19 patients
972
Prognostic Values of Various Markers in Evaluation of Patients With Chest Pain
973
Prognostic, predictive and therapeutic implications of HER2 in invasive epithelial ovarian cancer
974
Prognostic, therapeutic, and mechanistic implications of a mouse model of leukemia evoked by Shp2 (PTPN11) mutations
975
Prognosticating scale-forming properties of water
976
Prognostication and risk stratification by assessment of left atrioventricular plane displacement in patients with myocardial infarction
977
Prognostication in cancer of unknown primary (CUP): Development of a prognostic algorithm in 311 cases and review of the literature
978
Prognostication in Cardiac Patients
979
Prognostication of Breast Cancer in Ghanaian Women Receiving Modified Radical Mastectomy: A Retrospective Histopathological Study at Korle-Bu Teaching Hospital, Accra, Ghana
980
Prognostication of energy consumption and greenhouse gas (GHG) emissions analysis of apple production in West Azarbayjan of Iran using Artificial Neural Network
981
Prognostication of environmental indices in potato production using artificial neural networks
982
Prognostication of Learning Curve on Surgical Management of Vasculobiliary Injuries after Cholecystectomy
983
Prognostics
984
Prognostics 101: A tutorial for particle filter-based prognostics algorithm using Matlab
985
Prognostics 101: A tutorial for particle filter-based prognostics algorithm using Matlab
986
Prognostics and Health Management of PEMFC – State of the art and remaining challenges
987
Prognostics of lumen maintenance for High power white light emitting diodes using a nonlinear filter-based approach
988
Prognostics of lumen maintenance for High power white light emitting diodes using a nonlinear filter-based approach
989
Prognostics of PEM fuel cell in a particle filtering framework
990
Prognostics-based risk mitigation for telecom equipment under free air cooling conditions
991
Prognotic Factor Analyi in Par Plana Vitrectomy for Retinal Detachment Attributable to Macular Hole in High Myopia: A Multicenter tudy Original Reearch Article
992
Prognotic factor in uveal melanoma
993
Prognotic factor influencing viual outcome of photodynamic therapy for ubfoveal choroidal neovacularization in pathologic myopia
994
Prognotic value of cell-cycle marker in ocular adnexal lymphoma: an aement of 230 cae
995
PROGRA2 experiment: New results for dust clouds and regoliths analogs Original Research Article
996
Progradation of the paleo-Danube shelf margin across the Pannonian Basin during the Late Miocene and Early Pliocene
997
Prograde and retrograde history of the Junction School eclogite, California, and an evaluation of garnet–phengite–clinopyroxene thermobarometry
998
Prograde destruction and formation of monazite and allanite during contact and regional metamorphism of pelites: petrology and geochronology
999
Prograde garnet growth along complex P–T–t paths: results from numerical experiments on polyphase garnet from the Wölz Complex (Austroalpine basement)
1000
Prograde garnet-bearing ultramafic rocks from the Tromsø Nappe, northern Scandinavian Caledonides
بازگشت